The financial foundation that has supported American research universities for nearly eighty years is under acute stress. NIH indirect cost reimbursements — which universities use to fund the labs, compliance infrastructure, and administrative apparatus that make sponsored research possible — have been targeted by caps that would leave major research institutions absorbing hundreds of millions of dollars in previously reimbursed costs.13,16 Direct grant funding has contracted simultaneously: NIH funded 5,564 fewer grants in fiscal 2025 than in fiscal 2024 — a decline of roughly 8.6%25 — and the number of investigators winning R01-equivalent awards fell from 7,720 to 5,885 over the same period.18
The downstream effects are already measurable. PhD admissions at major research universities fell 15% for fall 2026, the second consecutive year of significant decline.27 Graduate stipend competition has intensified as universities scramble to retain top students with fewer funded positions available. USF, which has invested heavily in its research enterprise and achieved AAU membership, faces these headwinds at exactly the moment its research capacity is positioned for maximum impact.
This is the context in which building on USF's existing commercialization infrastructure makes compelling strategic sense. When federal funding contracts, the ability to generate royalty income, industry contracts, and startup activity from existing intellectual property becomes an increasingly important component of a sustainable research enterprise — and USF has already laid important groundwork toward that goal.
American research universities have operated for nearly eighty years on a stable financial foundation: federal research grants supplemented by indirect cost reimbursements that fund the laboratories, infrastructure, compliance, and administrative apparatus required to do science. That foundation has become unstable.
The Indirect Cost Reimbursement Crisis
The most consequential single development of 2025 was the federal attempt to cap indirect cost reimbursements at 15% of grant value.13 To understand why this matters, one must understand what indirect costs actually fund. They are not, as some critics have characterized them, administrative overhead. They cover laboratory space, scientific equipment, information technology, research security, data processing, biosafety, financial and accounting support, and legal and compliance support — the entire operational infrastructure that allows federally funded science to take place.
Universities have historically negotiated indirect cost rates with federal agencies based on demonstrated actual costs. These rates frequently exceed 50%, meaning a research university receives roughly 50 cents in indirect cost reimbursement for every direct research dollar awarded.15 In February 2025 the National Institutes of Health announced unilaterally that it would cap indirect costs at 15% on all grants. The Department of Energy followed in April; the National Science Foundation in May.13
For USF specifically, this would have represented an approximately 70% reduction in indirect cost reimbursement26. Federal courts later struck the cap down — a January 5, 2026 ruling by the U.S. Court of Appeals for the First Circuit held that NIH could not unilaterally impose the cap11 — but the litigation continues, and the policy intent remains. Future administrations may attempt similar caps through different mechanisms. The era in which research universities could rely on stable indirect cost reimbursement has ended.
Direct Grant Funding Reductions
Figures in this section reflect reporting available through mid-2026. Federal funding data for fiscal 2025 and 2026 was revised repeatedly during this period; readers checking against later sources may find updated numbers.
Direct grant funding has also contracted, and at NIH the contraction is visible in both dollars and awards. The Association of American Medical Colleges (AAMC) reports that the NIH obligated nearly $5 billion less for extramural research in the year ending June 30, 2025, than in the year before.7 Within that total, funding for new grants and competitive renewals fell to $8.6 billion from $10.5 billion, an 18% reduction.7 (The AAMC defines its fiscal year as July through June rather than the federal October–September year, so its figures do not align exactly with NIH’s own reporting.) The investigator success rate fell to roughly 17%, down from 26% the year before and the lowest level in nearly three decades, according to United for Medical Research.25 (NIH’s own success rate for R01-equivalent awards is reported separately as 13.0% in FY2025, down from 18.7% in FY2024.19 The two figures measure different things: United for Medical Research reports the share of research-grant applicants — people — who received an award, across all research grants, while NIH’s figure is the share of R01-equivalent applications funded. Both fell sharply; they are not interchangeable.)
Part of the decline in new awards reflects a change in accounting rather than a smaller appropriation. The NIH expanded its use of multiyear, or “forward-funded,” awards, which obligate the entire multi-year cost of a grant in the fiscal year it is made rather than one year at a time. A four-year grant that would once have encumbered a quarter of its value in year one now encumbers all of it, leaving less of that year’s appropriation available for anything new. The AAMC has documented the practice accelerating, and Congress capped it in a subsequent appropriations act.8,5 The effect on any individual investigator is the same whether the cause is a smaller budget or a differently obligated one: fewer competitive awards to apply for.
NSF made approximately 8,800 new research project grants in FY2025, down from roughly 11,000 the year before — a 20% decline.12 Earlier in 2025 the short-run picture was sharper still: an independent analysis of NSF’s public award database by David Miller, reported in Science, found the agency issued 919 new awards between the January inauguration and 27 March against 1,707 in the same period a year earlier.22
The federal government experienced a 43-day shutdown in late 2025, during which grant reviews were suspended entirely.6 The President’s FY26 budget request proposed approximately $27 billion for NIH, down from roughly $47 billion — a cut of about 40% — and $3.9 billion for NSF, a reduction of roughly 57%.14 Congress has so far rejected the deepest of these proposed cuts5, but the political pressure on research funding has not abated.
The Effect on Graduate Education
The contraction in federal research funding flows directly into graduate education. Graduate students at research universities are typically funded through faculty research grants. When grants are cut, frozen, or uncertain, the safest response for a faculty member is to admit fewer students.
The peer-institution data is striking. Harvard’s Faculty of Arts and Sciences initially cut science PhD admissions by more than 75%31, a reduction it subsequently moderated to roughly half29; Molecular and Cellular Biology was reduced to 4 new students; Chemistry and Chemical Biology, to four or five.31 Columbia GSAS proposed reducing the incoming PhD cohort by up to 65%.28 UC San Diego Biology cut admissions by more than 30%.30 Stanford, Yale, Brown, USC, Boston University, Penn, Wisconsin, Michigan State, and Washington have all scaled back, paused, or frozen new PhD admissions across multiple programs.30,32 Stanford reduced independent funding for bioscience graduate students from four years to two years.33
The NSF Graduate Research Fellowship Program — the gold-standard federal fellowship that has supported more than 70,000 fellows since 1952, more than 40 of whom have gone on to receive Nobel Prizes21 — saw its FY2026 budget request cut to $127.29 million, a 55.3% reduction against the $284.52 million in its FY2024 current plan.20
USF faculty have privately reported that PhD admissions have been reduced significantly for Fall 2026, mirroring documented cuts at peer institutions. The institutional fact books that would confirm this in numerical terms have not yet been published; the contraction is too recent. Faculty members live with this reality on a day-to-day basis. The data lags by months or years.
USF’s Position in This Environment
USF has navigated the 2025 funding environment more capably than most. The university secured a record $750 million in research funding in 2025 and gained more than $184 million in philanthropic support.35 It now ranks No. 2 among Florida’s public universities for active research activity.35 Tuition for nonresident students rose 10% in 2025 with another 15% increase approved for fall 2026.37
These figures demonstrate two things. First, USF’s leadership is already operating in the mindset that revenue diversification is essential. Second, USF is succeeding at parts of that diversification — particularly philanthropy. A venture center is the missing piece. It is a vehicle that captures economic value from research USF is already conducting and converts that value into licensing revenue, startup equity, and economic development for the Tampa Bay region.
The argument is not that a venture center will replace federal funding. No mechanism can. The argument is that prudent universities in this environment build multiple revenue streams. USF has built one. It has the foundation to build another.
Most research universities have a Technology Transfer Office. Very few have a robust venture center with positive net revenue. The distinction is not merely semantic — it is operational, financial, and cultural.
A traditional TTO is primarily a legal and administrative function: it files patents, negotiates licenses, and manages compliance. Its staff are predominantly attorneys and licensing managers. Its primary metrics of success are the number of patents acquired and the number of licenses executed. It is fundamentally reactive — responding to faculty disclosures as they arrive.
A Venture Center is a commercialization enterprise. It employs industry-experienced business development professionals alongside attorneys. It actively scouts promising research, recruits entrepreneurs-in-residence, creates startup infrastructure, and builds relationships with investors and corporate partners before deals are needed. Its metric of success is economic impact: royalty income, startups formed, jobs created, and follow-on investment attracted. The distinction is not a criticism of any particular institution's TTO — it reflects a deliberate strategic choice about the mission and scope of the commercialization function.
USF has already taken meaningful steps in the venture center direction. Through USF CONNECT, the university operates the Tampa Bay Technology Incubator (TBTI), which has supported companies that have collectively attracted $180.2 million in external funding40. The Foundation Bull Ring Accelerator Grant (BRAG) provides up to $25,000 per company to early-stage USF-licensed startups, and the Seed Capital Accelerator Program (SCAP) provides up to $50,000 in loan funding41. The Student Innovation Incubator, developed in partnership with the Florida High Tech Corridor, the Nault Center for Entrepreneurship, and Hillsborough County, further expands the ecosystem. These programs represent the foundational architecture of a venture center — and a strong base on which to build.
Of 115 AUTM member research universities analyzed in 2022, 58 (50%) operated at net positive royalty revenue; of the 113 in 2024, 47 (42%) did so.1,3 Those institutions have generally made deliberate investments in venture center infrastructure at scale. The data suggests that the programs already in place at USF, if expanded and resourced at a level commensurate with USF's research volume, have the potential to shift USF's position substantially.
There are no formal, official definitions of these terms. The boundary between a Technology Transfer Office and a Venture Center exists on a continuum. But the operational difference is real and observable.
The Traditional TTO Model
Many smaller TTOs are staffed by a single patent attorney whose job description is narrowly defined as “obtain patents.” These offices report difficulty declining to patent inventions of dubious commercial merit, even when subject-matter analysis would suggest the patent costs are unlikely to be recovered. The cultural and operational mandate of such offices is acquisition of intellectual property, not commercial assessment.
Larger TTOs typically have additional staff — perhaps an officer tasked with writing license agreements, perhaps an analyst assessing technologies for protection. But it is rare for a TTO to retain subject matter experts on call to evaluate commercial viability, even though doing so could save substantial money on patenting technologies that ultimately go nowhere. TTOs in general are active when it comes to acquiring intellectual property protection but relatively passive when it comes to the other tasks necessary to get technology out into the world — licensing, startup formation, corporate engagement, fundraising.
The Venture Center Model
A robust venture center with positive net revenue has at minimum, individuals or teams responsible for each of the following functions:
- Technology Assessment. Individuals with broad knowledge across technology domains and a budget to retain subject matter experts when needed. The output is a reasoned decision about whether to spend the substantial sums required to obtain utility patents. By avoiding patent costs on commercially nonviable inventions, this function pays for itself.
- Intellectual Property Protection. Experienced patent attorneys who engage and coordinate with outside patent law firms as needed.
- Faculty Outreach. A two-way relationship with faculty: educating researchers about IP and what they should and shouldn’t do to preserve patentability, while developing operational visibility into what research is happening across the university. The empirical record (Section 5) shows that strong faculty outreach correlates with rapid increases in invention disclosures and startup formation.
- Corporate Outreach. Long-term relationships with companies that may eventually become licensees or sponsors. Successful venture centers learn what industry needs and convey that information back to faculty, which can productively inform research directions.
- Aggressive Licensing Efforts. Listing patents in a database and waiting for licensees to find them is generally futile. This is essentially a sales effort, and like any successful business a venture center needs people who make warm and cold calls, follow up on unanswered communications, and persistently identify potential licensees and engage them. It is work for people who will not take no for an answer until they have had the opportunity to show the IP to a potential licensee.
- Structured Licensing. The mission of a university is not to make money with its technologies but to benefit society. License agreements must therefore generate royalty income and, at the same time, contain performance requirements that prevent a licensee from shelving the IP — acquiring patents simply to keep them from competing with existing products. Escalating minimum royalty clauses are a useful tool. This requires drafting expertise that goes beyond standard contract law.
- Startup Formation. Supporting faculty and student entrepreneurs in forming companies around university IP, including guidance on company structure, founding agreements, and the relationship between the startup and the university’s licensing terms.
- Investor Relations. Sustained relationships with venture capital firms, angel investors, and strategic corporate partners, so that startups emerging from university research reach the people who fund them rather than searching for capital unaided.
- Funded Incubator. Most successful venture centers run a funded incubator that provides not only physical space and capital, but also business mentorship to startups arising from university research. Funding sources vary — university general funds, wealthy alumni, family offices, industry grants, foundations, public-private partnerships, local economic development authorities — but the presence of a funded incubator is a defining characteristic of the venture center model.
- Development. Fundraising from government sources, philanthropic donors, family offices, foundations, and economic development authorities. Most successful venture centers were established with outside money rather than university operating funds (see Section 8). This function requires personnel with a track record in private fundraising.
These ten functions are the working definition of a venture center used throughout this analysis.
The AUTM STATT (Statistical Access for Technology Transfer) database is the authoritative source for university technology transfer performance data, covering its member institutions annually. The author obtained the complete 1991–2024 dataset1 and constructed a net revenue ranking for the 115 research universities meeting the inclusion criteria described below.
Which institutions are ranked, and why
The rankings cover AUTM member universities reporting at least $100M in annual research expenditures — 115 institutions in 2022 and 113 in 2024.1 The threshold restricts the comparison to institutions whose research base is of a scale comparable to USF’s, which is what makes a ranking meaningful: USF’s commercialization performance is informative when set against universities of similar research volume, and not when set against institutions with programs a fraction of its size. Hospitals, standalone research institutes, and AUTM aggregate rows are excluded, as are institutions not reporting the fields required to compute net revenue.
Total expense is computed as reported licensing and other FTEs valued at $240,000 fully loaded, plus reported legal fees. The basis for the $240,000 figure, and its effect on the rankings, is explained in Section 9 under Cost Assumptions. Where an institution reports FTEs but leaves the legal-fee field blank, legal fees are treated as zero; total expense is then staffing alone, which understates it. USF’s 2024 figure is computed on this basis. Institutions that report no FTE data at all cannot be ranked and are excluded — the University of Florida among them. Net revenue is gross licensing income less that total. Applying these criteria to the AUTM STATT database reproduces the tables below exactly.
The methodology is straightforward: for each institution, FTE overhead is calculated at $240,000 per FTE per year (licensing FTEs plus other FTEs), and total expenses equal FTE overhead plus patent legal fees. Net revenue equals Gross License Income minus Total Expenses. Institutions are ranked by Net Revenue using the most recent available year (primarily 2024).
The findings are striking. Only 58 of 115 research universities (50%) generated net positive royalty revenue in 2022, and only 47 of 113 in 2024 (42%).1,3 The top gross income performer is the University of Pennsylvania, which earned extraordinary income in excess of $1 billion from its patents on mRNA technology1,78 — demonstrating the transformative financial impact that a single foundational patent portfolio can deliver. The median profitable institution generated about $5.3M net in 2022 and $4.8M in 2024.1,3 The institutions operating at a loss averaged approximately $2.4M in net losses in 2022 and $2.6M in 2024, meaning their TTO costs exceed their licensing income.1,3 The most efficient TTOs are not the largest ones. Sixteen institutions returned more than 2× their total expense in 2022, and thirteen did so in 2024.1,3 Click the button below to see the schools ranked by ROI.
USF's relative position improved; its absolute performance did not. USF ranked 59th of 115 in the 2022 data and 48th of 113 in 2024.1 That movement is relative rather than absolute. Over the same period USF's gross licensing income fell from $4.82M to $3.48M and total expenses fell from $4.86M to $3.60M, leaving the net result slightly further below breakeven — ($34,124) in 2022 and ($117,058) in 2024.1,3 USF moved up the ranking primarily because peer institutions declined further, not because its own licensing revenue grew.
That is the finding this report is built around. USF's research volume ($461M in FY2023 research expenditures)44 is broadly comparable to institutions generating many times its royalty return. The gap between what USF puts into research and what it recovers from commercialization has not narrowed on its own, and there is no indication in the data that it will.
Of 115 AUTM member research universities analyzed in 2022, 58 (50%) operated at net positive royalty revenue. In 2024, 47 of 113 (42%) were net positive. USF ranked 59th of 115 in 2022 and 48th of 113 in 2024, essentially breaking even in both years.1
To complement the quantitative STATT analysis, the author held eight semi-structured interviews with technology transfer professionals from eight universities: Johns Hopkins, Duke, the University of Pennsylvania, the University of Utah, the University of Colorado (Anschutz Medical Campus), the University of Chicago, UC San Diego, and UC Riverside. The interviews took place March 2–4, 2025, at the AUTM 2025 Annual Meeting in National Harbor, Maryland2, and followed a common set of questions: how the office is organized, how it has changed, who drove the change, and what made the greatest difference. The people interviewed work in licensing, intellectual property, contracts and venture functions; not all of them head their offices. No participant is named or quoted in this report. Everything below is the author’s paraphrase, and interview accounts have been checked against public records wherever such records exist. The method and its limitations are described in the last panel of this section.
Most of the eight offices have brought the core functions under one roof. Licensing, intellectual property protection, startup support and industry partnerships typically sit under a single leader or a single umbrella organization rather than in separate units that must coordinate across reporting lines. The scale varies widely — from a five-person technology transfer team at UC Riverside to roughly 75 people at Penn2 — but the pattern of consolidation holds at both ends of that range. One interviewee whose office had made exactly this consolidation described the common reporting line as what keeps the parts communicating rather than working in isolation.
The clearest common thread was authority. Wherever the history of an office could be established, from the interview, the public record, or both, the change depended on someone with the power to hire and to fund — a president, a chancellor, a vice president for research, or a chief innovation officer given a mandate — and on university leadership’s willingness to keep funding the office as it grew. Several of these decisions are documented publicly. At Johns Hopkins, the president and the dean of the School of Medicine commissioned the faculty committee whose 2014 report led to $40 million in new university investment and the creation of Johns Hopkins Technology Ventures75,76. At UC San Diego, the chancellor created the Office of Innovation and Commercialization in 201577. At Duke, the president announced in 2021 a restructuring that placed translation and commercialization within a new Office for Research & Innovation74. Who first pushed for change varied from one institution to the next; that it was backed by leadership with real authority did not.
Asked what had made the greatest difference, most interviewees pointed to that leadership support and to what it paid for: the right people, a patent budget, gap funding, and startup support. Two named operating disciplines instead — attentive service to faculty combined with hard-headed review of the patent portfolio, and the work of finding the right industry partners. None described a documented model linking particular changes to particular outcomes; these transformations ran on intent, resources and experienced people. The accounts that addressed how change was carried out favored building new capability around an existing office, and keeping its experienced staff and institutional knowledge, over replacing them — and interviewees also described what happens when change is carried out badly, discussed below and in Section 9.
Expand any topic below for detail:
The table below describes each office as it stood in March 2025. Sizes are the interviewee’s own description unless a public source is cited2; where an interview estimate and a public source differ, the public source is used.
| Institution | Office | Size | How it is organized |
|---|---|---|---|
| Johns Hopkins | Johns Hopkins Technology Ventures (JHTV) | About 45 in the technology transfer office — roughly the same number as before JHTV was created | Three functions under one organization: technology transfer, itself split into licensing and IP management; FastForward startup support (space, staff, mentors and grant funding); and corporate partnerships responsible for sponsored research76. All of the growth came in the capability built around the licensing office rather than in the office itself. |
| Duke | Office for Translation & Commercialization, within the Office for Research & Innovation | Compact: a licensing team of five or six, two in-house patent attorneys, technology marketing staff, and a two-person new ventures group | Patent and licensing; technology marketing, with paid and trained graduate students writing market assessments; and new ventures, supported by contracted mentors-in-residence rather than direct investment. An affiliated investor network, Duke Capital Partners, invests in Duke startups. |
| Pennsylvania | Penn Center for Innovation (PCI) | About 75, grown from a few dozen when PCI was formed about ten years earlier | Licensing in three divisions (physical sciences, the School of Medicine, and the other professional schools), alongside PCI Ventures for startups and a corporate alliances group for large multi-investigator relationships. PCI has no investment fund of its own. |
| Utah | Technology Licensing Office (formerly the PIVOT Center), reporting to the Vice President for Research80 | Functional teams, each with its own lead | Technology assessment; commercialization teams for the physical and life sciences, which own faculty relationships and marketing; contracts; finance; compliance, including monitoring licensees’ ongoing obligations; IP; and marketing. Technologies suited to a startup are handed to a separate university team for company formation. |
| Colorado (Anschutz) | CU Innovations | About 20, six of them in licensing | Licensing, business development, marketing, finance and compliance groups, each with a director who sits on a leadership team; an in-house patent agent; close working ties with university counsel. |
| Chicago | Polsky Center for Entrepreneurship and Innovation | Not established in the interview | One umbrella over an education arm (I-Corps programming, accelerators, classes) and a technology arm with four divisions: business development, licensing and marketing; IP; a venture group with an affiliated early-stage fund of about $20 million; and accelerator programs. Budget and hiring authority rest with an associate vice president. |
| UC San Diego | Office of Innovation and Commercialization (OIC) | More than 30 staff79 | A startup group, physical sciences licensing, life sciences licensing, and IP, plus finance, reporting to an associate vice chancellor. Created by the chancellor in 2015 to bring technology transfer, IP and industry partnering under one roof77. One leadership post became three when its holder retired. |
| UC Riverside | Office of Technology Partnerships | Five in technology transfer — four licensing officers and one IP analyst — managing about 500 active IP assets | Three pillars under one leader: technology commercialization; corporate and strategic partnerships; and innovation and entrepreneurship, which also serves the surrounding community through small-business and SBIR/STTR resource centers. |
Terms: TTO — technology transfer office. IP — intellectual property. SBIR/STTR — the federal Small Business Innovation Research and Small Business Technology Transfer grant programs. I-Corps — the National Science Foundation’s Innovation Corps commercialization training program. JHTV, PCI and OIC are the office names given in the table. The University of California campuses report to AUTM as a single system, so UC San Diego and UC Riverside have no campus-level entries in the STATT data used elsewhere in this report.
The interviews do not support a single story about where change begins. At one institution the president drove it personally. At another a newly appointed chief innovation officer was given the task of redesigning the office from scratch. At a third, the push came from faculty who were dissatisfied with the service they were receiving; the vice president for research and a largely faculty search committee recruited an experienced leader and gave that person wide latitude. At a fourth, a vice chancellor conceived the combined structure, and it took shape once a dedicated associate vice chancellor was hired. At a fifth, the president set an ambitious public goal for commercialization, and a new vice president for research and a new office head reset the office’s priorities to meet it. At a sixth, a retirement allowed one leadership post to become three.
What did not vary was the source of the authority. In each of these cases the change was backed from the top of the research enterprise — a president, a chancellor, or a vice president for research — even where the first push came from somewhere else. What mattered was not where the office sat on the organizational chart but whether the people backing it held real power over budgets and hiring; at one institution in the set, that power rests explicitly with the associate vice president who leads the combined office.
Culture before structure. At Johns Hopkins, the account given was that the university first had to become comfortable with commercial activity — the committee’s own 2014 report acknowledges Hopkins’ long history of keeping private-sector partnership at arm’s length — and only then turned to reorganizing the office75. That report also gave, in 2014, a reason for investing that reads as current today: in a period of federal research austerity, revenue from commercialization can be reinvested in future research.
Legitimacy through consultation. The Hopkins committee was faculty-led and included faculty who had successfully taken inventions to market. It posted its draft recommendations publicly in April 2014, held town-hall meetings, and took comments from more than a hundred faculty, students, staff and outside stakeholders before issuing a final report of 22 recommendations grouped under space, funding, and resources and policies75. The implementation plan followed ten months later76. The report is public, and it offers a university considering a venture center a tested template for building consent rather than imposing change.
Resources had to be sustained, not just committed. Interviewees repeatedly distinguished a one-time launch from a leadership that keeps funding the office as it grows. Two resourcing paths appear in the set: at Penn the office grew from a few dozen people to about 75 over a decade; at Hopkins the licensing office held steady at about 452 while all new investment went into startup support, space and corporate partnerships around it.
Each interviewee was asked directly which single factor had made the greatest difference to the office’s results. The answers, paraphrased and not attributed:
- Leadership at the top that stands behind the office’s policies and practices, without which the office is caught between competing pressures and cannot drive to an outcome.
- A visionary leader for the office, together with university leadership willing to fund that vision at the outset and to keep funding it as it grew.
- Administrative support in the form of investment — hiring the right people and giving them resources: a patent budget, gap funding in the laboratory, and entrepreneurial support.
- Building a startup support capability, without which the office would not have achieved its licensing results, kept startups in its region, or grown its early-stage activity.
- Building a complete ecosystem: teaching, cross-campus collaboration, active outreach, and dedicated space for startups.
- Service to faculty, combined with disciplined review of the patent portfolio so that money stops being spent on technologies with no prospect of value.
- Finding the right industry connections, backed by market research on who the major players are and which companies license outside technology.
Five of these answers point to leadership, the resources leadership provides, or capabilities those resources built. Two point to operating disciplines. The eighth interviewee questioned the premise, describing the office’s progress as continuous improvement rather than a discrete change. It is worth noting that the two operating answers describe what an office must do well now, while the others describe what made past change possible; the two kinds of answer are complementary rather than contradictory.
No explicit theory of change. Interviewees were also asked whether their leadership had described how particular policy or structural changes were expected to produce particular improvements. None described such a model. The Hopkins plan, the most fully documented of the eight, sets out 22 recommendations without mapping any of them to a specific outcome75. Where the reasoning was described at all, it was that leadership hired experienced people and trusted them to determine what needed to be done and measured.
The objection that a venture center is only for institutions the size of Hopkins or Penn is answered in part by the interviews themselves. Several of the practices below cost little, and one office in the set runs its entire technology transfer function with five people.
- Market actively; passive listing does not work. Two offices independently reported that posting available technologies on a website or in an exhibit-hall database produces very few licenses. Licenses come from outreach: cold calls, industry contacts, and in one office literally walking the halls to meet faculty who have never disclosed an invention.
- Industry collaborators are the likeliest licensees. Companies already sponsoring or collaborating on a faculty member’s research tend to become the front-runners to license what that research produces. Several interviewees expected industry-sponsored research to grow in importance as federal funding tightens — the same pressure described in Section 1.
- Free the licensing officers to sell. A five-person office created a single IP analyst position to manage outside patent counsel, office actions and deadlines for all four licensing officers, who had previously spent much of their time on prosecution. It is a small-scale version of the licensing/IP split that larger offices make with whole departments.
- Use trained graduate students for assessment and marketing. One office pays and trains graduate students to write market assessments of new technologies; another uses an internal academy of doctoral students and postdoctoral fellows to write its technology assessments.
- Review the portfolio by inventor, not by patent. One office holds a demanding quarterly review of its entire portfolio, organized around inventors rather than individual patents, because many inventors are serial and the office must know what each is actually working on. The governing question is why the office is still spending money on each patent.
- Triage early and set clocks. One office sorts new disclosures into four tiers, separates startup candidates from licensing candidates, and commits a minimum number of outreach attempts to each top-tier technology. It tracks internal cycle times — disclosure to a written assessment with a go/no-go decision, request to executed agreement — as management metrics alongside the external AUTM measures.
- Fund the experiment that decides the question. Proof-of-concept funds described in two of the interviews made awards in the range of $50,000 to $100,0002 to faculty, not startups, for the single experiment, data set or prototype needed to decide whether to form a company or to attract a licensee. One takes no equity in return.
- License what cannot be patented. One medical campus reported that much of its licensing involves tangible research materials — cancer cell lines with specific mutations, antibodies, hybridomas and mouse models — protected by the terms of the license rather than by patents. For mouse models, a national repository holds and distributes the lines once a license is in place. This is a revenue and impact channel that involves no patent expense at all, and a pointed counterexample to patent counts as a measure of success.
- Measure the right thing. One interviewee suggested counting the number of distinct technologies licensed rather than the number of license agreements, since a single agreement can cover dozens of technologies and a dozen agreements can cover one. Several described their office’s purpose as impact, with royalty income a by-product of doing many good deals rather than a goal in itself.
- Treat conflicts of interest as manageable. One office actively teaches faculty that financial interest in their own research is not wrong in itself — it must be disclosed and managed.
- Protect founders from dilution. One institution takes a small equity stake in its startups, about 1%2, and protects it from dilution through to exit, where many offices ask for more at the start and accept dilution.
Peers share what they know. Several interviewees said their offices readily share practices with other universities, and one office is mentoring a much smaller university’s office under a funded program, helping it build processes and metrics suited to its own scale rather than copying its mentor’s structure. A university considering a venture center does not have to design one alone.
The interviews were not limited to success. Three accounts describe change that went badly, and together they bear directly on the selection-bias limitation discussed in Section 9: they show, from inside, how a university can form or reorganize a commercialization office and fail to get the results documented in Section 5. None of the institutions is identified, because each account characterizes a program unfavorably on the strength of one person’s recollection.
A leader without technology transfer experience. An interviewee described a well-performing program that was placed under a new leader with deep industry credentials but no understanding of university technology transfer. The new leader reorganized the office in a way that removed experienced staff, and with them the office’s knowledge of its own portfolio and inventors — knowledge the interviewee regarded as essential and impossible to capture fully in any database. Within about eighteen months2 the program had collapsed, the leader had departed, and the university recruited a highly experienced technology transfer executive to rebuild it.
A startup function without the supporting functions. Another interviewee described an early effort to promote faculty startups that was launched before the mentoring, training and infrastructure to support them existed. Faculty incorporated companies and licensed their technology, but were then left largely on their own; the result was a handful of startups that existed mainly on paper. The program became effective only years later, once the supporting functions were in place.
An over-correction. A third office described a period in which its leadership shifted effort heavily toward startups and the entrepreneurial community. Relationships with faculty — the source of every invention — deteriorated, and a subsequent leader reversed course to put faculty first.
These accounts are consistent with the chain-link argument in Section 2: a venture center that implements some of the core functions but neglects others, or that discards the experienced people who make the functions work, can do worse than the office it replaced. They are also consistent with the published literature cited in Section 9, which finds that how a technology transfer office is run explains much of the difference in outcomes between institutions.
How the interviews were conducted. The author held eight semi-structured interviews, one per institution, on March 2, 3 and 4, 20252, at the AUTM 2025 Annual Meeting at the Gaylord National Resort in National Harbor, Maryland. Each followed a common set of questions, developed with the guidance acknowledged in the author’s note. The conversations were informal, and the author sometimes shared his own working views with participants; they should be read as practitioner conversations, not as blinded research interviews.
Attribution. Participants were contacted after the meeting about attribution. So that all eight are treated alike, no participant is named or quoted, and the report presents what they said in the author’s own words. Facts about how an office is organized are reported by institution, because they describe institutions rather than individuals. Opinions, and accounts that reflect unfavorably on any institution, are reported without identifying the institution. The views summarized here are those of individual professionals and are not official positions of their universities.
Selection. The eight institutions are a convenience sample of offices whose staff were available at the meeting, not a set chosen for superior performance. Because the University of California campuses report to AUTM as a single system, UC San Diego and UC Riverside could not be ranked individually, and they were included in part to learn how smaller or less visible offices operate. The sample leans toward large, well-resourced research universities.
Verification. Interview accounts are self-reported. Where an account could be checked against public records it was, and where the two differ the public record is used. Participants who had joined their office after a change took place were treated as witnesses to current practice rather than to the history of the change, and statements they offered as guesses about that history are not reported as findings.
The central empirical question of this analysis is whether venture center formation produces measurable, durable improvements in technology transfer outcomes. Eleven peer institutions were examined; seven met the inclusion criteria set out in Section 9.1 Across those seven, the answer is consistent: every metric measured is higher after venture center formation than before.
The aggregate findings are shown below as the ratio of the post-formation annual average to the pre-formation annual average. Years 1–5 are the mean across the 7 qualifying institutions; years 6–10 the mean across the 6 institutions with sufficient data in that window. Licenses issued is the exception: two institutions report no pre-formation license counts, so that row rests on 5 institutions in years 1–5 and 4 in years 6–10.1,3
- Royalty Income: 3.61× in years 1–5; 5.79× in years 6–10 — royalty income ran 3.6 times the pre-center level during the first five years, and 5.8 times the pre-center level during years 6–10.3 Duke reached more than 12 times by year 11.1,3
- Industry Contracts: 1.62× in years 1–5; 2.23× in years 6–10 — sponsored research funding from corporate partners was about 60% higher than the pre-center level in years 1–5, and more than double the pre-center level in years 6–10.3
- Licenses Issued: 1.53× in years 1–5; 2.14× in years 6–10 — the number of licenses executed each year rose by about half in years 1–5, and slightly more than doubled in years 6–10.3
- Patents Issued: 2.11× in years 1–5; 2.81× in years 6–10 — annual patent output more than doubled in years 1–5, and rose to nearly three times the pre-center level in years 6–10.3
- Invention Disclosures: 1.45× in years 1–5; 1.65× in years 6–10 — faculty submitted about 45% more inventions to the technology transfer office each year in years 1–5, and about 65% more in years 6–10.3
- Startups Formed: 2.12× in years 1–5; 3.43× in years 6–10 — the number of new companies formed each year more than doubled in years 1–5, and more than tripled in years 6–10.3
All six metrics continue to increase in years 6–10. The chart below shows all three periods side by side.
How Robust Is the Royalty Result?
Because a single institution can dominate a small sample, the headline royalty figure was subjected to four checks, all documented in Section 9 and reproducible from the supporting workbook.3
- Leave-one-out. Recomputing the aggregate seven times, omitting each institution in turn, yields a range of 3.22× to 3.97×.3 No single institution drives the result.
- Median alongside mean. The middle institution of the seven returned 3.66×, slightly above the 3.61× mean — so the finding is not the product of a single exceptional performer.3 This check is explained below.
- Alternative specification. Replacing the full pre-formation baseline with a symmetric five-year-before / five-year-after window yields 2.96×.3 The estimate is lower but the conclusion is unchanged.
- Effect of the exclusions. The two institutions excluded for thin pre-formation data would have contributed 1.94× (MIT) and 7.76× (Colorado).3 Re-including both raises the aggregate to 3.89×. The exclusions are net conservative: they cost the analysis 0.28× rather than flattering it.
Taken together: royalty income at qualifying institutions roughly tripled in the first five post-formation years under either specification, and the result does not depend on any one institution.
Why Both an Average and a Median Are Reported
Two kinds of average appear in this analysis, and the difference between them is worth a sentence. The mean is the familiar one: add the seven institutional ratios together and divide by seven. The median is the middle value when those same seven ratios are lined up from smallest to largest. A mean can be pulled upward by one exceptional institution; a median cannot, because it reports what the institution in the middle of the pack actually did.
Reporting both is a standard robustness check. If the two diverge sharply, the average is being carried by an outlier and should be treated with caution. If they agree, the result is broadly distributed across the group. For the headline royalty finding they agree closely: mean 3.61×, median 3.66×.3 The median is in fact marginally the higher of the two, meaning the typical qualifying institution did slightly better than the average — not worse.
The same broad agreement holds across most of the six metrics. The two exceptions are licenses issued and invention disclosures, where the median rises less than the mean in the 6–10 year window. Both of those rows rest on the fewest reporting institutions, so their middle value shifts substantially when a single institution enters or leaves the sample. Medians for all six metrics, in both time windows and under both specifications, are tabulated in Section 9 and in the supporting workbook.
Against what baseline? Licensing income at 96 AUTM member universities without a venture center was analyzed over the same era (2014–2024). The median institution recorded a ten-year ratio of 0.98× — flat, or −0.2% per year — and 52% ended the decade with lower licensing income than they began it1,3, as blockbuster patents expired without pipeline replenishment. The gains documented above are therefore not a rising tide: over a full decade, the typical university without a venture center went nowhere. Every institution in that comparison is listed in the supporting workbook.
Mean Pre- vs. Post-Venture Center Performance
Average across 7 qualifying peer institutions — Pre-VC indexed to 100
The charts below compare USF's current performance profile against Duke University — selected for two reasons. First, Duke is the only institution in the study with no data gaps, providing the cleanest longitudinal comparison. Second, and equally important, Duke's research enterprise at the time it formed its Venture Center (2010) was closely comparable to USF's today: a major AAU research university with strong medical and engineering programs, solid patent output, and royalty income averaging $7.6M across its pre-formation period — the range USF occupies now, though Duke’s final two pre-formation years were higher, at $15.6M and $19.0M.1 Each chart below plots Duke and USF together on a single shared vertical axis, one commercialization metric at a time, so the two institutions can be compared directly without the distortion that separate axis scales introduce. The horizontal axis is expressed in years relative to venture center formation: year 0 is 2010 for Duke, the year its venture center was formed, and 2024 for USF, the most recent reporting year. The dashed vertical line marks year 0. Because USF has not formed a venture center, its series necessarily ends at that line. USF's data gap (2016–2018) reflects a period of incomplete STATT reporting; some series are also unreported for 2019–2021, and these gaps appear as breaks in the USF line rather than as interpolated values.
Reading these charts: The following graphs can be difficult to read, so their structure is explained here. The lines in these graphs do not represent the same calendar years for Duke and USF. Rather, they are years relative to venture center formation. The lines for Duke cover the 5 years prior to venture center formation in 2010 through the 5 years after — that is, the years 2005–2015. Since USF has not yet formed a venture center, the lines for USF cover only the 5 years prior to venture center formation, that is, the years 2019–2024.
Interpreting these charts: Four metrics are shown, chosen because they track the commercialization pipeline from beginning to end: invention disclosures measure to what degree faculty bring their discoveries forward; legal fees measure to what degree the university sought to protect the IP; patents issued measures the success of protecting the IP; and gross license income measures whether the protected IP reached the market, returning financial value to the university and delivering university IP to the world where it could benefit society.
- Invention Disclosures: USF and Duke had a comparable number of invention disclosures in the 5 years prior to venture center formation, and those numbers were relatively flat, with the caveat that USF achieved an abrupt increase from 200 to 275 disclosures between 2022 and 2024, suggesting that it has likely made new, effective efforts to encourage such disclosures. Duke had a dramatic increase in invention disclosures following venture center (VC) formation, doubling the number of invention disclosures from 200 to 400 in the 5 years following venture center formation.1
- Legal Fees: USF’s legal fees have been flat. Duke’s legal fees, by contrast, have more than doubled in the 5 years following VC formation, indicating that it is making concrete efforts to secure protection for its university-generated IP, effectively keeping pace with the increased number of invention disclosures.1
- Patents: USF is clearly effective at obtaining patents, acquiring between 80 and 110 patents per year in the years 2019–2024. Duke was less prolific, acquiring between 22 and 45 patents per year in the 5 years prior to VC formation. However, that number took off after VC formation, tripling in the following 5 years.1 One can speculate that in the years prior to VC formation, Duke was more selective than USF in deciding what to patent, and that since VC formation it has decided that more of its IP is worth protecting.
- Gross License Income: This is where the effectiveness of forming a VC really shines. USF’s gross royalties have been flat, never exceeding $2.4M (according to the AUTM database).1 Duke, on the other hand, has achieved a remarkable increase in gross licensing income since VC formation, with a more than 5× increase since VC formation and now exceeding $100M annually.1
⚠ Years with missing data reflect periods when UNC did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when the University of Michigan did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when UMass did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when the University of Kansas did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when the University of Colorado did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when Ohio State did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when MIT did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when Johns Hopkins did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when Emory did not report to AUTM STATT — shown as gaps in the charts above.
⚠ Years with missing data reflect periods when the University of Utah did not report to AUTM STATT — shown as gaps in the charts above.
A necessary caveat — selection bias. The institutions analyzed here formed venture centers and went on to report strong results. This report does not examine institutions that formed venture centers and did not. That is a genuine limitation, and it is structural rather than accidental: in university technology transfer, success is announced and failure is quietly absorbed back into the existing office, leaving little public record to find. No amount of searching fully corrects it.
The published literature does address the question with full-population samples. Studies covering all 113 US university technology transfer offices in the AUTM survey, and comparable work in the UK95,93, confirm that commercialization performance varies widely and that under-performance is common. Critically, that research attributes the variation primarily to organizational design and execution — faculty reward systems, staffing and compensation practices, and institutional policy choices — rather than to research volume or regional advantage. One study found no effect of local venture capital availability on start-up formation.94
The conclusion this report supports is therefore a specific one: a venture center that is well executed can produce results of the magnitude shown above — and execution is what decides the outcome. That is precisely why the ten core functions in Section 2 are presented as requirements rather than as a menu. The full discussion, with citations, appears under Selection Bias: The Institutions Not Studied in Section 9.
The central empirical question of this analysis is: do venture centers actually deliver measurable improvements? The answer, based on AUTM STATT data across eleven institutions, is yes — though with several important caveats discussed throughout this section and in Section 9.
Methodology
Data was extracted from the AUTM (Association of University Technology Managers) STATT (Statistic Access for Technology Transfer) database for eleven institutions with venture centers established between 1998 and 2019.1 For each institution, annual data was collected for several metrics: royalty income, industry contract revenue, licenses issued, patents issued, invention disclosures, and startups formed. Years were anchored relative to venture center formation (year 0 = formation year, with positive years following and negative years preceding).
For the cross-institution aggregate analysis, seven of the eleven institutions met the inclusion criteria — at least four usable observations in both the pre-formation baseline window and the post-formation window, under both specifications described in Section 9. Requiring an institution to qualify under both specifications, rather than either one, is the stricter test. Post-VC averages use the first five post-VC years only (or all available if fewer than five were completed at time of data extraction). This windowed approach ensures like-for-like comparisons and avoids conflating early gains with later compounding. Four institutions were excluded from the mean:
- MIT — one royalty observation in the five years preceding formation. Its longer baseline is also unusable in substance: a six-year reporting gap separates $4.8M (1995) from $77.0M (2001)1, so an average across all pre-formation years is not a meaningful baseline regardless of the observation count.
- University of Colorado — three royalty observations in the five years preceding formation.
- Johns Hopkins — an AUTM reporting gap in 2016–2018 leaves only two of the first five post-formation years.
- Emory University — excluded on grounds of specification instability; see Section 9.
All four institutions’ per-institution data are preserved in the supporting workbook.
For each qualifying institution, the average annual value of each metric was computed across pre-formation and post-formation years separately, then a post/pre ratio was calculated. Aggregate ratios reported below are means of those per-institution ratios across the seven qualifying institutions. Medians and a leave-one-out range are reported in Section 9.
Aggregate Findings
| Metric | Post-VC vs Pre-VC Ratio | Interpretation |
|---|---|---|
| Royalty Income | 3.61× | Royalty income more than tripled in the first 5 post-VC years |
| Startups Formed | 2.12× | Annual startup formation more than doubled |
| Patents Issued | 2.11× | Annual patent issuance more than doubled |
| Licenses Issued | 1.53× | Annual license execution increased substantially |
| Invention Disclosures | 1.45× | Faculty engagement with the IP process rose meaningfully |
The royalty income finding is the headline result: across seven qualifying institutions, average annual royalty income in the first five post-VC years was 3.61× the pre-VC level (median 3.66×).3 This is the metric that most directly reflects the core mission of a venture center — converting university intellectual property into licensed products that generate revenue for the university and bring inventions into the world. Importantly, as the section below on long-term compounding shows, 3.61× is the floor, not the ceiling; royalty growth accelerates substantially in years 6–10 and beyond.
Startup formation more than doubled (2.12×), reflecting the venture center model’s explicit emphasis on company formation as an alternative path to commercialization. Patents issued more than doubled (2.11×), driven by both increased filing activity and — importantly — better screening that prevents expenditure on commercially nonviable inventions. License execution rose 50% and invention disclosures rose 46%3, indicating that faculty engagement with the IP process strengthened materially after venture center formation.
Secular Baseline: Royalty Growth Without a Venture Center
A natural question is whether the gains observed above simply reflect a rising tide across all university technology transfer programs. To answer this, gross licensing income from the AUTM STATT database was compared between 2014 and 2024 for every AUTM member university that reported in both years, excluding only the eleven institutions examined elsewhere in this report. That yields 96 comparison institutions.1,3 Institutions are matched between the two years by AUTM identifier and, where an identifier changed, by name — both are required, since nine institutions kept their name but were reassigned an identifier while one changed name and kept its identifier. Four institutions AUTM reclassified between 2014 and 2024 are retained. No performance-based filter was applied: excluding high performers would define the comparison group by its outcome and bias the baseline downward. Some of the 87 do operate venture centers, which makes this baseline conservative — it works against the argument advanced here rather than for it.
| Finding | Value |
|---|---|
| Median 10-year licensing income ratio (96 universities, 2014–2024) | 0.98× — flat |
| Median annualized growth rate | −0.2% per year |
| Institutions with lower licensing income in 2024 than in 2014 | 52% |
| Implied correction to the 3.61× result for background growth | ≈1.0 — no correction needed |
The finding is striking: without a venture center, the median university saw licensing income essentially unchanged across the full decade 2014–2024 — while the venture-center institutions studied here reached 3.61× within five years of formation. Many schools experienced steep declines as blockbuster patents expired without pipeline replenishment — Princeton fell from $143.0M to $36.2M, Rochester from $25.6M to $2.3M, and Georgetown from $8.7M to $635K.1 This is the structural problem that a venture center solves: continuous identification, protection, and licensing of new IP replaces the revenue lost as older patents expire. The secular correction factor is effectively 1.0, meaning no discount to the 3.61× VC result is warranted for background growth. The gains are attributable to the venture center model itself.
Short-Term Gains and Long-Term Compounding
The 3.61× royalty figure reported above reflects only the first five post-VC years — the period in which the new program is still building its pipeline. For institutions with sufficient longitudinal data, the trajectory is consistently upward: early gains are sustained and amplified as the portfolio of licensed IP matures and new deals layer on top of earlier ones.
| Time Window | Royalty Growth vs. Pre-VC | Notes |
|---|---|---|
| Years 1–5 post-VC | 3.61× | Mean across 7 qualifying institutions (median 3.66×); leave-one-out range 3.22–3.97× |
| Years 6–10 post-VC | 5.79× | Mean across the 6 institutions with complete data (median 5.96×); range 2.29× (U Mass) to 8.82× (Michigan). Every metric’s mean grows vs. years 1–5. |
| Years 11+ post-VC | 12×+ | Duke 12.7× avg (Yrs 11–13); Michigan 12.5× avg (Yrs 11–21) |
Across the six institutions with complete years 6–10 data (UNC, Michigan, UMass, Kansas, Utah, Duke), the mean royalty ratio rises from 3.61× in years 1–5 to 5.79× in years 6–10 — and every other metric grows as well. Duke’s individual trajectory illustrates the long-run potential: from $7.6M pre-VC to $30M in years 1–5, $51M in years 6–10, and exceeding $90–100M by years 11–13 (12–14× overall).1,3 Michigan averages 12.5× across years 11–21.1,3 The 3.61× five-year figure is the entry ramp, not the destination.
A Note on Industry Contract Revenue
Across the eleven venture centers studied, industry contract revenue — payments from corporations to universities for sponsored research — substantially exceed royalty income at most institutions, often by an order of magnitude. Hopkins routinely receives over $120 million annually in industry contracts; Duke approached $250 million in the post-VC period; MIT exceeds $130 million; Ohio State, $140 million.1 Some readers will reasonably ask why this metric is excluded from the central analysis above.
The answer is that industry contract revenue, while financially important, does not advance the core mission of a technology transfer office. Industry contracts are essentially fee-for-service arrangements: a corporation pays the university to perform research that primarily benefits the corporation. The intellectual property generated typically flows to the corporate sponsor, not back to the university for licensing. This is closer to contract R&D than to commercialization of university-owned IP.
The mission of a venture center, properly understood, is to take university-developed intellectual property and place it in the hands of those who will use it for the public good — through licenses to existing companies or through new startups built around it. Royalty income, while smaller in dollar terms than industry contracts, is the metric that directly measures success at this mission. Industry contracts are an important secondary benefit of having a venture center’s corporate-outreach function, but they should not be confused with the core work.
Caveats and Limitations
Several caveats accompany these findings. First, the comparison is non-randomized: the institutions that established venture centers may differ systematically from those that did not, in ways that themselves predict commercialization outcomes. The data cannot fully isolate the venture center “effect” from broader institutional reforms (new leadership, increased research budgets, etc.) that often accompanied venture center formation.
Second, AUTM STATT data is self-reported by member institutions, with reporting gaps in some years that make trend analysis difficult. Patent counts in particular can be inflated by aggressive filing strategies and should be interpreted with care.
Third, royalty income is heavily influenced by occasional “blockbuster” licenses that are difficult to predict and not necessarily attributable to venture center formation — the reason Emory is excluded from the aggregate and reported separately (Section 9). The 3.61× aggregate ratio survives leave-one-out testing and an alternative baseline specification; readers should not, however, infer that any single new venture center will reliably produce a 3.61× increase in its sponsoring institution’s royalty income. The aggregate describes a set of institutions, not a forecast for any one of them.
Fourth, all dollar figures are nominal and unadjusted for inflation. Because the primary specification draws its baseline from every available pre-formation year — in one case spanning more than two decades — the symmetric five-year specification is reported alongside it as a check.
USF and UF: Same State, Different Commercialization Investments
The University of Florida and the University of South Florida are both AAU-designated, state-preeminent research universities drawing from the same Florida talent base, competing for the same faculty and graduate students. They are 120 miles apart. Yet their technology commercialization infrastructure differs substantially — and not because of research quality.
An important caveat: UF reports gross licensing income to AUTM ($58.1M in 2022, $39.3M in 2024)1 but does not report the staffing and legal-expense fields required to compute net revenue. It therefore cannot appear in the net-revenue rankings in Section 3, and a direct quantitative comparison using the methodology applied to the eleven peer institutions in this report is not possible. The analysis in Sections 3 and 5 of this report is limited to AUTM member institutions.
What is publicly known is that UF operates the UF Office of Technology Licensing (OTL), which has been active since the 1980s87, and the UF Innovate initiative, which provides incubator space, proof-of-concept funding, and startup support services. UF also operates the Florida Innovation Hub in Gainesville, which houses early-stage companies. Its first phase — 48,000 square feet, funded by an $8.2M Economic Development Administration grant together with $5M from UF — opened in 201186; a second phase, funded by $8M from the EDA and $9M from UF, opened in 2018 and roughly doubled the facility to 100,000 square feet.85 These are the kinds of infrastructure investments that the peer institutions studied in this report made over the past two decades — and which USF has not yet made at comparable scale.
The point of the UF comparison is not to cite specific numbers — it is to make the case that a peer institution in the same state, competing for the same talent and industry relationships, has invested deliberately in commercialization infrastructure. When the same faculty, the same graduate students, and the same industry partners have a choice between an institution with a funded venture center and one without, the institution that has made the investment has a meaningful competitive advantage in recruiting and retaining the researchers whose work generates licensable IP.
USF's position in the AUTM net-revenue ranking moved from 59th of 115 in 2022 to 48th of 113 in 2024.1 That movement reflects peer decline more than USF growth: USF's own gross licensing income fell over the same period. The research base described above is not currently being converted into commercialization output at the rate peer institutions achieve, and it is that gap — not the ranking — that a venture center is designed to close.
The first question this analysis raises is what a venture center costs. The peer record answers it directly, bracketed by actual expenditures across a wide range of institutional contexts.
Documented entry commitments at the peer venture centers ranged from about $3M (the University of Colorado’s Deming Center, 1998)51 to $40M (Johns Hopkins, new university investment over five years, 2015)76, with several between $10M and $20M. The wide range reflects very different strategic ambitions and timelines. Larger figures sometimes quoted for these centers — the $65.6M building in which Hopkins’ FastForward occupies space59, or the $45M Lassonde Studios at Utah66 — are facility costs or later fundraising rather than the cost of starting a center, and are treated separately below.
Sizing a program appropriate to USF is properly USF’s work, not this author’s. What the peer record establishes is the order of magnitude, and one consistent feature across every institution studied: the sum was treated as something to be raised rather than something to be budgeted. Whatever figure USF arrives at, the peer experience indicates it is a capital investment with measurable returns — a 3.61× average royalty increase in the first five years, rising to a mean of 5.79× by years 6–10.3
What does a venture center cost? The answer is bracketed by what peer institutions have actually spent.
Initial Investments at Peer Venture Centers
The following table summarizes the initial startup investments that could be documented from public sources, covering eight of the eleven universities examined. Figures are entry commitments — the money that launched each center — with later gifts and facility costs noted where they are relevant. The fifth column shows reported royalty income in 2022, the most recent year for which complete data was available across all institutions.
| University | Venture Center | Year | Initial Investment | 2022 Royalty1 |
|---|---|---|---|---|
| Johns Hopkins | JH Tech Ventures (FastForward) | 2014–2015 | $40M (university, over 5 yrs)76 | $32M |
| Duke | Duke Innovation & Entrepreneurship Initiative | 2010 | No lead gift at launch; $15M gift in 201254 | $95M |
| Ohio State | Keenan Center for Entrepreneurship | 2018 | $17M61 | $18M |
| Emory | Goizueta Center for Entrepreneurship & Innovation | 2019 | $30M gift, shared65 | $279M |
| U Michigan | Zell Lurie Institute | 1999 | $10M; +$60M in 201569,71 | $20M |
| U Utah | Lassonde Entrepreneur Institute | 2006 | $13M; +$12M toward the $45M Studios (2014)62,66 | $34M |
| MIT | Deshpande Center for Technological Innovation | 2002 | $20M63 | $82M |
| U Mass | Venture Development Center, UMass Boston | 2009 | Not publicly disclosed | $41M |
| U Colorado | Deming Center for Entrepreneurship | 1998 | $3M51 | $24M |
A note on what this table does and does not show. Single-year royalty income at these institutions is generally large relative to what their venture centers cost to establish — Ohio State, whose center is the most recent on the list, generated $18M in 2022 against a $17M initial investment.1,61 But a single year’s royalty income is not a return on that investment, and this report does not present it as one. Royalty income at any research university reflects licenses executed over decades, and at several institutions here a single blockbuster dominates the figure. The causal evidence is in Section 5, which measures the change in royalty income before and after venture center formation at each institution. This table establishes scale, not attribution.
Emory is the clearest case where the two must be separated. The Goizueta Center for Entrepreneurship & Innovation is a business school center supporting student ventures; it did not generate Emory’s licensing income. Emory’s 2022 figure derives from its Office of Technology Transfer and from Drug Innovation Ventures at Emory (DRIVE), a not-for-profit drug development company wholly owned by the university and established in 2013 with more than $20M in internal funding56,55 — itself financed in part by the proceeds of Emory’s 2005 sale of its emtricitabine royalty interest for $525M.57 DRIVE licensed molnupiravir, which accounts for the 2022 spike55,1 and for its subsequent decline as COVID-19 antiviral sales fell. Emory is therefore retained as a case study — and an unusually complete one, in which commercialization proceeds were reinvested into a purpose-built venture vehicle that produced a globally significant drug — but it is excluded from every aggregate in this report. Section 9 documents the exclusion and the specification testing behind it.
These ratios understate the case, because royalty income from any single year does not capture the cumulative value generated by a venture center over time. They also do not capture industry contract revenue, startup equity, regional economic development effects, or faculty retention benefits. They are simply the cleanest single comparison available.
Entry Commitment, and What Came Later
A single headline number can make the task look larger than it was. In most cases below, the figure that launched the venture center is not the figure the institution eventually raised, and the two are separated by years of demonstrated results. Reading them as one number overstates what it takes to begin.
Two distinctions matter. The first is timing: entry commitments were phased, typically over five years, not delivered as a lump sum. The second is sequence: at most of these institutions, the larger money arrived after the center existed and had something to show. That is the pattern USF should expect — not a single transformational gift at the outset, but a credible start that makes the next conversation possible.
| Institution | Entry commitment | Source of the entry funds | What came later |
|---|---|---|---|
| Johns Hopkins | $40M over five years (2015)76 | The university’s own budget — new investment under its 2014 innovation report | Space in the $65.6M 1812 Ashland building (a building cost, largely non‑venture); philanthropic translational funds59 |
| Duke | Initiative launched Oct 201054 | University-launched; no lead gift at inception | $15M from trustee and alumnus David M. Rubenstein, May 2012 — about eighteen months after launch54 |
| Ohio State | $17M commitment (June 2018)61 | Keenan Family Foundation; Tim Keenan is a 1980 alumnus | No subsequent commitment identified in public sources |
| MIT | $20M gift funding the center’s initial phase (2002)63 | Jaishree and Gururaj “Desh” Deshpande | Additional industry and foundation support; the center has since deployed about $22M in grants across 221 projects53 |
| U Michigan | $10M endowment (1999)69 | Samuel Zell and Ann Lurie | $60M pledged by the Zell Family Foundation in 2015 — sixteen years later71 |
| U Utah | $13M initial donation (2006)62 | Pierre Lassonde and the Lassonde Family Foundation | $12M more toward the Studios facility (2014); a further $25M in May 2025, doubling the family’s total to $50M — nineteen years after entry66,52 |
Several Models to Choose From
The eleven institutions have far more in common than they differ, but they do vary in structure and in what they were originally built to do. Johns Hopkins and Duke built commercialization enterprises at or alongside the technology transfer office. Ohio State and Michigan built entrepreneurship centers within their business schools. MIT’s Deshpande Center began as a translational research fund in the School of Engineering. The rest sit at points along the same continuum, several combining elements of more than one.
That variety is an advantage, as there is no single blueprint a university considering a venture center is obliged to copy, and no institution whose organizational chart has to be reproduced to get the result. The models can be weighed against a university’s own governance, its existing programs, and its research strengths, and the arrangement that fits best adopted — or elements borrowed from several.
What does not vary is function. Whatever the reporting line, these centers all have industry-experienced business development staff with individuals dedicated to faculty and corporate outreach, protecting IP, aggressive licensing efforts, startup formation supported by a funded incubator, and investor relationships. Structure is a choice but function is specified. Whatever blueprint a university adopts, all ten of the functions set out in Section 2 need a home somewhere within it.
This report does not propose a figure for USF; that determination belongs to USF. What the peer record does establish is that this is rarely a request against an operating budget. Johns Hopkins and Duke funded their own launches, and outside money followed; most of the other venture centers on this list were established primarily with outside funding — gifts from alumni, foundations, family offices, state economic development authorities, or public-private partnerships. The funding model is discussed in Section 8.
A feature of the venture center model that is frequently overlooked in initial discussions is that a university’s operating budget is rarely the main source of a venture center’s money. Most of the venture centers studied here were built largely with outside funding — from individual philanthropists, family foundations, alumni, corporations and economic development authorities.
Johns Hopkins and Duke funded their own launches — Hopkins with $40M of university money over five years76, Duke with no lead gift at inception — and in both cases outside money followed once the center existed and had something to show: Duke received a $15M gift from trustee David M. Rubenstein about eighteen months after launch.54 Ohio State's Keenan Center was established by a $17M commitment from the Keenan Family Foundation.61
USF's philanthropic context is favorable. The university reported $184 million in philanthropic support in FY202535, and single gifts of $20 million and $25 million have already named its colleges of medicine and business36,42. The challenge is not identifying potential donors — it is presenting them with a compelling, credible, data-supported case for what a USF Venture Center would accomplish. That is precisely what this report is designed to do.
How Peer Venture Centers Were Funded
A review of the eleven venture centers in this analysis reveals a consistent pattern:
- Johns Hopkins Technology Ventures (FastForward) was launched with a $40 million commitment of new university investment over five years, announced in March 2015 as the implementation plan for the university’s 2014 innovation report.76 FastForward later took 23,000 square feet in 1812 Ashland60, a $65.6 million laboratory and office building59 that also houses unrelated Johns Hopkins labs and offices; that construction cost is a building cost, not a venture center cost, and is excluded here.
- Duke’s Innovation & Entrepreneurship Initiative launched in October 2010; trustee and alumnus David M. Rubenstein’s $15 million gift followed in May 2012, roughly eighteen months after the initiative was already running.54
- Ohio State’s Keenan Center was established with a $17 million pledge from the Keenan Family Foundation in 2018.61
- Emory’s Goizueta Center was funded by a gift from the Goizueta Foundation in late 2019.50 The $30 million commitment — the largest in the business school’s hundred-year history65 — supported three initiatives, of which the center for entrepreneurship and innovation was one; the share attributable to the center alone is not publicly broken out.
- Michigan’s Zell Lurie Institute was founded with a $10 million endowment from Sam Zell and Ann Lurie in 1999, with an additional $60 million in 2015 to expand programs.69,71
- Utah’s Lassonde Institute and Studios were funded by a $13 million initial donation from Pierre Lassonde, with an additional $12 million for the Studios facility (Lassonde’s total gifts reaching $25M, with the remainder of the $45M Studios facility funded by the university and other donors).62,66 In May 2025 the Lassonde Family Foundation committed a further $25 million, doubling the family’s total support to $50 million — nineteen years after the entry commitment, and twenty-four years after the institute began as a single small program.52,62
- MIT’s Deshpande Center was established in 2002 with a $20 million founding gift from Jaishree and Gururaj “Desh” Deshpande.63
- UMass Boston’s Venture Development Center opened in May 200964,70 in an 18,000-square-foot renovated cafeteria space in Wheatley Hall48 and has operated on a self-funding basis.67 No public record of a founding appropriation or lead gift could be located, and none is claimed here.
- Colorado’s Deming Center was founded with a $3 million gift from the Deming family in 1998.51
- KU Innovation Park was funded by a public-private partnership including the Kansas Bioscience Authority, City/County funds, the University, and the KU Endowment.68
The pattern is consistent. Nearly every center on this list was built with outside money — individual donors, family foundations, state economic development authorities, or public-private partnerships. Where the university funded the launch itself, as at Johns Hopkins and Duke, outside money followed once there was something to show rather than preceding it. Either way the university’s own financial commitment is the smaller and earlier part of the total; the platform, the research base, and operational governance are what the university reliably supplies.
Implications for USF’s Approach
This pattern reframes the proposition. The question for USF is not “can the university afford a venture center?” The question is “which potential donor or coalition of donors finds USF’s research base and the Tampa Bay innovation ecosystem compelling enough to fund the vehicle that captures its value?”
The candidates are not hypothetical. Donors in the region have already made gifts of this size to USF: Frank and Carol Morsani’s $20 million gift named the Morsani College of Medicine in 2011, and Pam and Les Muma’s $25 million gift named the Muma College of Business in 201436,42.
Outside donors typically have specific motivations: personal connections to a research area (a family member affected by a particular disease), commitment to local economic development, alignment with educational mission, or simply a desire to leave a named legacy at a regional flagship. A USF Venture Center fundraising effort can credibly speak to all of these. The institutional foundation — AAU membership, Preeminent designation, Morsani’s standing, the trajectory — makes the case at the level required by donors at this scale.
The practical first step is therefore not a budget request. It is a fundraising plan, led by USF’s development office in coordination with university leadership, that approaches identified donors with a specific proposal. Most of the peer entry commitments documented in Section 7, between $3 million and $20 million, are no larger than those two gifts.
This section documents the methodological choices and known limitations of the analysis for readers who wish to interrogate the empirical basis of the conclusions. The core analysis uses AUTM STATT data, which is self-reported by institutions and subject to variation in reporting practices. Several institutions have gaps in their historical data; the analysis notes these gaps explicitly in the per-institution charts.
The aggregate ratio analysis (Section 5) uses a before-after comparison rather than a randomized controlled design — venture center formation cannot be randomly assigned, and institutions that chose to invest in venture centers may differ systematically from those that did not. The analysis attempts to mitigate this through the selection of qualifying institutions (requiring at least four years of pre- and post-formation data) and through transparency about the causal inference limitations inherent in the design.
The most serious limitation is selection bias. This report examines institutions that formed venture centers and subsequently reported strong outcomes. It does not examine institutions that formed venture centers and did not, and it therefore cannot answer the question a skeptical reader will reasonably ask: how often does this fail? The bias is structural rather than accidental — in university technology transfer, success is announced and failure is quietly absorbed — and it cannot be corrected by assembling whatever failures happen to be publicly findable, which would be its own biased sample. What can be said is that the published academic literature addresses the same question using full-population samples that do not share this report’s selection problem, and consistently finds that performance varies widely across institutions95,94,93,92 and that the variation is driven by organizational execution rather than by research volume or regional advantage. The full discussion, with citations, is under Selection Bias: The Institutions Not Studied below.
This section documents the methodological choices and known limitations of the analysis, in greater detail than the brief notes embedded in earlier sections. It is intended for readers who wish to interrogate the empirical basis of the conclusions.
About This Revision
This report has been revised through successive drafts, each incorporating additional primary-source research and verification. Figures superseded during that process are noted where they appear, so that any earlier number a reader may have encountered can be reconciled against the current one. The underlying AUTM STATT data run through 2024 and the analysis does not depend on figures that turn over quickly.
Data Sources
Primary data was extracted from the AUTM STATT database, which reports annual technology transfer metrics from its member institutions. The complete 1991–2024 dataset was used. Reporting is voluntary and self-reported; institutions occasionally fail to report in particular years, leaving gaps in the longitudinal record. Where Excel was loading missing data as zero values, those cells were corrected to blank to prevent zeros from biasing the analysis.
Cost Assumptions
FTE personnel costs were estimated at $240,000 per FTE per year. The figure is intended as a fully loaded cost: salary, plus fringe benefits, plus the operating costs of keeping a professional in post — space, travel, databases and software, and administrative support.
For scale, the most recent AUTM salary survey freely available online (FY2014; later editions are available to subscribers only) reported median base salaries of $165,342 for technology transfer office directors, $126,455 for assistant or associate directors, $85,000 for licensing associates and $46,123 for administrative assistants72. Salaries have risen since. USF’s pooled fringe-benefit rates for FY2025 were 37.7% of salary for administrative and executive employees and 49.6% for staff73. At a 37.7% fringe rate, $240,000 corresponds to a salary of about $174,000 before any operating costs, or about $140,000 to $145,000 once operating costs of 20–25% of salary and benefits are added.73
That places the assumption at the upper end of the plausible range. It approximates the fully loaded cost of a senior licensing professional rather than the blended cost of an office that also employs junior and support staff. Its effect is to overstate expenses and understate net revenue, so the Section 3 finding that roughly half of research universities do not cover their technology transfer costs is, if anything, unfavorable to technology transfer offices generally. Because the same rate is applied to every institution it favors none of them, but offices with large staffs relative to their income are affected most, and a somewhat lower rate would move some institutions — USF among them, which in 2024 reported 15 FTEs and $3.48M in gross licensing income1 — from a small deficit to a small surplus. USF’s 2024 result stays close to zero across the plausible range: about $0.5M in surplus at $200,000 per FTE, and about $0.1M in deficit at $240,000.3 The observation that its program roughly breaks even is therefore not an artifact of the assumption.
Legal fees in AUTM STATT are reported gross and have not been adjusted for licensee reimbursement, which can materially reduce net legal expense. This means total cost figures in the analysis are conservative (likely overstating actual cost to the institution).
Specification
The analysis is an event study. Year 0 is the year the venture center was formed; outcomes are annual institution-level values drawn from the AUTM STATT database. For each institution and each metric, the reported ratio is the mean of the post-formation years divided by the mean of the pre-formation years.
- Primary specification (A). The pre-formation baseline is the mean of all available pre-formation years; the post-formation window is the first five post-formation years.
- Robustness specification (B). The pre-formation baseline is restricted to the five years immediately preceding formation, giving a symmetric five-year-before / five-year-after window. This is reported alongside specification A, not as a replacement for it.
Institutions are weighted equally. Each figure reported here is an average of averages: the ratio was calculated separately for each institution — its own post-formation annual average against its own pre-formation annual average — and those individual ratios were then averaged. The dollars were not pooled and divided once. The distinction matters because these institutions differ enormously in size: pooling would let the largest one or two set the figure for the entire group, while averaging the individual ratios gives every institution equal weight. Medians are reported alongside means throughout. All dollar figures are nominal and unadjusted for inflation — a limitation that matters most under specification A, where one baseline spans more than two decades, and the reason specification B is reported.
Inclusion Criteria
An institution enters the aggregate for a given metric only if it has at least four usable observations in both the pre-formation baseline window and the post-formation window for that metric, under both specifications — not merely one. Requiring an institution to qualify under the symmetric five-year baseline as well as the full baseline is the stricter test, and it is what excludes MIT and Colorado, whose all-years baselines contain enough observations but whose five-year windows do not. The rule is applied identically to the years 1–5 and years 6–10 analyses. Seven of the eleven institutions examined qualify for the years 1–5 royalty analysis; six qualify for years 6–10.
Four institutions are excluded, each for a stated reason:
- MIT (Deshpande Center, 2002): only one royalty observation in the five years preceding formation. Its longer baseline is unusable in substance as well as in count — a six-year reporting gap separates $4.8M (1995) from $77.0M (2001)1. MIT is excluded from both windows. Because the two windows share the same baseline, including MIT in one but not the other would be inconsistent. Its exclusion changes the years 6–10 royalty figure from 5.56× to 5.79×3; both figures are given here so that the published result can be reconciled against the underlying workbook.
- University of Colorado (Deming Center, 1998): three royalty observations in the five years preceding formation.
- Johns Hopkins (JH Tech Ventures, 2014–2015): an AUTM reporting gap in 2016–2018 leaves only two of the first five post-formation years.
- Emory University: excluded on grounds of specification instability. See below.
Why Emory Is Excluded
Emory is the one institution in the set whose estimated effect is not stable across defensible analytical choices. Computed four ways, its years 1–5 royalty ratio is:3
| Specification | Ratio |
|---|---|
| Year 0 = 2019, baseline = all pre-formation years | 2.60× |
| Year 0 = 2019, baseline = 5 preceding years | 11.28× |
| Year 0 = 2019, excluding the 2005 one-time sale | 7.97× |
| Year 0 = 2013 (DRIVE), baseline = all pre-formation years | 0.17× |
A sixty-fold spread across reasonable specifications means the Emory estimate is not identified. No other institution in the set varies by more than roughly 1.5× across the same choices.3 Two features of Emory’s data account for it:
- A one-time capital event in the baseline. Emory’s reported gross license income for 2005 is $585,656,7651,57 — the sale of its emtricitabine royalty interest to Gilead and Royalty Pharma, not annual licensing revenue. Included in a baseline of recurring income, this single figure raises Emory’s pre-formation average from roughly $13M to roughly $40M.1,3
- A one-time event in the post-formation window. Emory’s 2022 income of $279M reflects molnupiravir, the oral COVID-19 antiviral, and falls to $108M in 20231 as pandemic antiviral sales declined.
A third question compounds these: which Emory entity constitutes the venture center. The Goizueta Center for Entrepreneurship & Innovation, founded in 2019 and the most obvious candidate for year 0, is a business school program supporting student ventures; it does not license university patents. Emory’s commercialization vehicle is Drug Innovation Ventures at Emory (DRIVE), a not-for-profit company wholly owned by the university and established in 2013 with more than $20M in internal funding56,55 — itself financed in part by the 2005 emtricitabine proceeds. DRIVE licensed molnupiravir. Anchoring at 2013 rather than 2019 is defensible, and it produces the 0.17× figure above, because the 2013 post-window opens exactly as the legacy royalty stream expires.
Emory is therefore reported as a case study in Section 7 and excluded from every aggregate. Its full data remain in the supporting workbook, with the 2005 entry flagged, so that readers may verify this treatment. Including Emory under the published specification would have lowered the headline royalty figure, from 3.61× to 3.49×3; the exclusion is made on methodological grounds and is not directionally self-serving.
Sensitivity Analysis
The headline royalty result was tested three ways:3
- Leave-one-out. Omitting each qualifying institution in turn and recomputing gives means of 3.85×, 3.61×, 3.97×, 3.22×, 3.27×, 3.82× and 3.55× — a range of 3.22× to 3.97× around a full-sample mean of 3.61×.3
- Median. 3.66×, marginally above the mean, indicating the distribution is not right-skewed by an outlier.
- Alternative baseline. Specification B yields 2.96× (median 3.07×).3
- Effect of the exclusions. MIT and Colorado, excluded for thin pre-formation data, would have contributed 1.94× and 7.76×. Re-including both raises the aggregate from 3.61× to 3.89×.3 Together with the Emory case above, in which exclusion also raised the figure, the exclusions in this report are net conservative.
Every figure in this section is reproducible from the supporting workbook, where the per-institution ratios, the leave-one-out calculation, the exclusion-impact comparison, the full ranking universe for both years, and the Emory specification table are computed by formula rather than entered by hand. This now includes the secular baseline reported in Section 5: all 96 comparison universities are listed individually on the workbook’s Secular Baseline sheet, with the selection rule stated and the median, quartiles and decline share computed by formula from the listed figures.
Causal Inference Limits
The analysis does not establish a causal effect of venture center formation on commercialization outcomes. It establishes an association: institutions that formed venture centers experienced substantial increases in royalty income, startup formation, and faculty engagement metrics in the years following formation. Several plausible alternative explanations exist:
- Selection effects. The institutions that successfully formed venture centers may differ systematically from those that did not, in ways that themselves predict better outcomes.
- Confounded interventions. Venture center formation typically coincides with broader institutional reforms (new leadership, expanded research investment, faculty pressure for change). The effect attributed to the venture center may reflect this larger reform package.
- Royalty lag. Royalty income reflects licensing decisions made 5–20 years earlier. Some of the post-VC royalty growth observed at older venture centers reflects pre-VC research and licensing activity coming to maturity.
These caveats do not invalidate the central finding. They suggest that the venture center should be understood as the operational embodiment of comprehensive commercialization-oriented reform, rather than as the sole cause of better outcomes. For the purposes of a USF investment decision, the practical implication is the same: peer institutions that committed to the venture center model experienced substantial commercialization gains; the absence of such commitment correlates with stagnation.
Selection Bias: The Institutions Not Studied
The most serious limitation of this analysis deserves to be stated plainly rather than left for a reader to discover. This report examines institutions that formed venture centers and subsequently reported strong commercialization outcomes. It does not examine institutions that formed venture centers and did not. The seven institutions in the aggregate were not drawn at random from the population of universities that have attempted this; they are, in effect, institutions whose venture centers are still being described as successes years later. That is a selection bias, and it means the analysis cannot answer the question a skeptical reader will reasonably ask: how often does this fail?
The bias is difficult to remedy, for a structural reason worth naming. In university technology transfer, success is announced and failure is absorbed. An institution that launches a commercialization initiative issues a press release. An institution whose initiative fails to gain traction rarely issues a second one — the unit is quietly folded back into the existing technology transfer office, its web presence is retired, and the episode leaves little documentary trace. Any search for failed venture centers therefore under-counts them systematically. A handful of failures assembled from whatever happens to be publicly findable would constitute its own biased sample rather than a correction to this one, and this report does not attempt that exercise.
The published academic literature, however, addresses the underlying question using full-population samples, and it is worth citing precisely because it does not share this report's selection problem. Four studies are directly on point.
Siegel, Waldman and Link (2003)95 examined the productivity of university technology transfer offices using AUTM survey data covering 183 institutions for 1991–1996, reduced after exclusions to 113 US universities — including 80 of the 89 US institutions then classified as "Research 1." This is the whole field, not a curated subset. Their quantitative finding was that licensing activity exhibits constant returns to scale, and that environmental and institutional factors explain only part of the observed variation in performance. To explain the rest, they conducted 55 interviews with 98 entrepreneurs, scientists and administrators across five research universities95, and concluded that the most critical organizational factors are faculty reward systems, technology transfer office staffing and compensation practices, and cultural barriers between the university and industry. Their finding is that the variance is driven by how the office is run — not by how much research the institution produces.
Di Gregorio and Shane (2003)94 asked directly why some universities generate more start-ups than others, testing four competing explanations across the 1994–1998 period: the availability of venture capital near the university, the commercial orientation of university research, the university's intellectual eminence, and university policy choices. Their results are unusually relevant to USF's situation. They found that intellectual eminence, the policy of making equity investments in start-ups in lieu of patent and licensing costs, and maintaining a low inventor share of royalties all increased start-up formation rates. They found no effect of local venture capital activity, and only limited support for an effect of the commercial orientation of university research. In other words, the factors that distinguished high-performing universities were institutional decisions the university itself controls — not the surrounding regional economy.
Chapple, Lockett, Siegel and Wright (2005)93 applied data envelopment analysis and stochastic frontier methods to UK university technology transfer offices and likewise found substantial dispersion in relative efficiency, with many offices operating well below the performance frontier. Bercovitz, Feldman, Feller and Burton (2001)92 compared Duke, Johns Hopkins and Pennsylvania State, and tied differences in patenting and licensing behavior to differences in organizational structure and reporting relationships.
Taken together, these studies establish two things. The first is that commercialization performance varies widely across institutions and that under-performance is common — which is the honest correction to this report's sample. The second is more useful: the variation is attributable primarily to organizational design and execution, and only secondarily to research volume, institutional prestige, or regional advantage. Di Gregorio and Shane's null result on local venture capital is particularly worth noting, because the most natural objection to this report's peer comparisons — that Durham, Baltimore and Cambridge enjoy ecosystem advantages that Tampa does not — is the specific hypothesis their data did not support.
This report should therefore not be read as claiming that forming a venture center guarantees the outcomes documented in Section 5. The claim the evidence supports is narrower: a venture center that is well executed can produce results of the magnitude shown here, and seven institutions demonstrate it. What the literature adds is that execution is the variable that decides the outcome — which is why the ten core functions set out in Section 2 are presented as requirements rather than as a menu. An institution that adopts the name without the functions has, on this evidence, no particular reason to expect the results.
One further limitation follows from the same documentary problem. Even where an under-performing initiative can be identified, determining why it under-performed is generally not possible from public records: staffing levels, internal budget allocations, reporting lines, and leadership turnover are rarely published. The ten core functions in Section 2 are therefore presented as a normative specification drawn from the observed practices of the institutions studied here and corroborated by the organizational findings above — not as a hypothesis that this report has tested against failure cases.
USF occupies a strong and recognized position among American research universities. Its 2023 election to the Association of American Universities (AAU)91 — a distinction held by only 71 institutions in North America12 — reflects the quality and output of its research enterprise. Research expenditures grew from $405M in FY202183 to $461M in FY202344 and $522M in FY2024 — a figure that places USF 47th among the nation’s public universities, 69th among all reporting institutions, and 2nd among Florida’s public universities on the National Science Foundation’s Higher Education Research and Development (HERD) survey, and represents growth exceeding that of 90% of AAU members.38 USF reported $531M in research activity for FY202546; the HERD ranking reflecting that year had not been released at the time of writing. (HERD measures expenditures — money actually spent in a given year — rather than the value of new awards. The record $750M in FY2025 research funding35 noted in Section 1 is an awards figure; the two are different measures and are not directly comparable.)
By research volume, USF is comparable to institutions that have successfully established venture centers. The University of Utah had research volume of the same order as USF’s today when it established its Lassonde Entrepreneur Institute in 2006; it has since become a national model for university entrepreneurship, and its royalty income rose 2.36× in the first five years after formation.1,3 The comparison is not meant to minimize the work required — it is meant to affirm that USF already has the research foundation on which a successful venture center can be built.
What This Analysis Does Not Address
Several questions of likely interest to USF leadership are outside the scope of this analysis:
- Detailed organizational design: where a USF Venture Center would sit administratively, how it would relate to existing units, who would lead it.
- Specific donor identification or fundraising tactics, beyond the general observation that the regional donor base is plausibly capable of funding the effort.
- Forecasts of USF-specific commercialization outcomes following venture center formation, which would require institution-specific modeling beyond the cross-institution comparisons presented here.
These questions are more appropriately addressed by USF leadership and operations staff, working with development professionals, in subsequent planning phases. The analysis presented here is intended to establish the case in principle and quantify the upside; the operational design follows once the principle is accepted.
Two university imperatives described in the preceding sections are aligned. One is financial — research funding is tightening, and institutions are looking harder at ways to increase income from their intellectual property. The other has nothing to do with budgets and predates the current squeeze — the obligation to move discoveries out of the laboratory and into the world, where society can benefit from them. Commercialization serves both. The eleven institutions examined in this report responded the same way: they built dedicated commercialization enterprises, funded them, and let them operate as something other than compliance offices.
The results did not reveal a scattering of success stories but a consistent pattern. Among the institutions qualifying for the outcome analysis, six commercialization metrics were measured — royalty income, industry-sponsored research, licenses executed, patents issued, invention disclosures, and startups formed. In every one of these six metrics, there were substantial gains in years 1–5 that continued to grow in years 6–10.3
That happened against a flat tide, not a rising one. Across 96 AUTM member universities over the same period, the median institution’s royalty income was essentially unchanged, and slightly more than half declined outright.1,3
There is no single blueprint. The eleven centers vary in structure and what they were built to do. But they have far more in common than not: whatever the organizational chart, the successful cases all instituted the same core functions. For an institution weighing the question, that is good news — several models work.
The limits of this analysis should be stated plainly. This is an observational study of institutions that chose to build venture centers, not a controlled experiment, and those institutions may differ in ways the data cannot capture — leadership, appetite for risk, the strength of the research portfolio underneath. Two of the eleven were excluded from the aggregates for reasons given in the methodology, and entry costs are not comparable across institutions.
The pattern is strong, consistent, and directionally clear though not proof of causation.
The University of South Florida sits in a position several of these institutions occupied before they made their own decisions: a large and growing research enterprise, a commercialization record that trails its research standing, and no dedicated venture center. As USF evaluates its IP commercialization enterprise, the experiences of these eleven peers may provide useful reference points.
This report makes a case; it does not propose a plan. Three possible next steps, in ascending order of commitment:
- A conversation. Thirty minutes to walk through the data and the peer comparisons, and to hear where the argument does not hold.
- Validation. Someone within USF Research & Innovation checks the AUTM STATT figures used here against USF’s own records. The supporting workbook is structured so that this can be done directly.
- A joint approach. USF Research & Innovation and the USF Foundation together develop a proposal and approach identified prospects. Section 8 sets out why this is the funding path the peer record supports.
The author has no formal relationship with USF, no financial interest in the outcome, and nothing to sell.
Primary data: AUTM STATT Database (1991–2024). Eight semi-structured interviews with technology transfer professionals (AUTM 2025 Annual Meeting, March 2–4, 2025). Federal research funding data: NIH Research Portfolio Online Reporting Tools (RePORTER); NSF Higher Education Research and Development Survey. USF-specific data: USF Research & Innovation public reporting.
Superscript numbers in the text refer to the numbered entries below. Hover over a number to see the source’s short name; click it to jump here, then use “Return to text” to go back. Entries are grouped by topic and alphabetical within each group.
Primary Data
- AUTM STATT Database (Statistic Access for Technology Transfer), Association of University Technology Managers. Annual reports through 2024.
- Eight semi-structured interviews conducted by the author with technology transfer professionals at Johns Hopkins University, Duke University, the University of Pennsylvania, the University of Utah, the University of Colorado Anschutz Medical Campus, the University of Chicago, UC San Diego and UC Riverside; AUTM 2025 Annual Meeting, National Harbor, Maryland, March 2–4, 2025. Participants are not named or quoted; see Section 4 for method and limitations.
- Supporting Excel workbook: Venture Centers USF Gold Standard v68 (embedded in this file — click to download) — per-institution data, the Methods and inclusion criteria, the revised aggregate analysis, and the robustness checks (leave-one-out and specification sensitivity).
Federal Research Funding Environment
- ‘A huge rupture in everything’: US science faced major upheaval in 2025. (2025, December). Chemical & Engineering News. https://cen.acs.org/policy/nih-nsf-ostp-science-research-funding-cuts/103/web/2025/12
- American Association for Cancer Research. (2026, April 14). Cancer policy monitor: April 14, 2026. https://www.aacr.org/professionals/policy-and-advocacy/aacr-cancer-policy-monitor/cancer-policy-monitor-april-14-2026/
- American Association of Immunologists. (2025, November 19). Federal government reopens following longest shutdown in history. AAI News. https://news.aai.org/2025/11/19/federal-government-reopens-following-longest-shutdown-in-history/
- Association of American Medical Colleges. (2025, August 15). NIH awards billions of dollars less in research funds [Data brief]. https://www.aamc.org/media/85501/download
- Association of American Medical Colleges. (2026, May 26). Multiyear funding of NIH research grants [Data brief]. https://www.aamc.org/media/89991/download
- Association of American Universities. (2025–2026). Federal research cuts threaten U.S. innovation and leadership. https://www.aau.edu/key-issues/federal-research-cuts-threaten-us-innovation-and-leadership
- Bedekovics, G., & Ragland, W. (2025, July 23). Mapping federal funding cuts to U.S. colleges and universities. Center for American Progress. https://www.americanprogress.org/article/mapping-federal-funding-cuts-to-us-colleges-and-universities/
- Commonwealth of Massachusetts v. National Institutes of Health, No. 25-1343 (1st Cir. Jan. 5, 2026), 2026 WL 26059 (affirming injunction against NIH’s 15% indirect-cost-rate cap).
- Despite Trump chaos, NSF avoided feared dip in research financing. (2025, November 19). Science. https://www.science.org/content/article/despite-trump-chaos-nsf-avoided-feared-dip-research-financing
- Epstein Becker Green. (2025, May). National Science Foundation (NSF) imposes 15% indirect cost rate cap: What to know. Health Law Advisor. https://www.healthlawadvisor.com/national-science-foundation-nsf-imposes-15-indirect-cost-rate-cap-what-to-know
- Federation of Associations in Behavioral & Brain Sciences. (2025, June). FY26 President’s budget request slashes funding for science, health, and education. https://fabbs.org/news/2025/06/fy26-presidents-budget-request-slashes-funding-for-science-health-and-education/
- Ford, E. W., & Huerta, T. R. (2025). The financial impact of NIH’s indirect cost cap on higher education research. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxaf094
- Fore, P. (2025, March 6). Universities that anticipate funding losses from Elon Musk’s DOGE cuts are yanking back admission offers to graduate students. Fortune. https://fortune.com/2025/03/06/university-elon-musk-doge-cuts-rescind-genz-graduate-school-offers
- Forrest, P., Judd, R., & Pittman, S. (2025, November 12). Higher education’s uncertain fiscal future. The Pew Charitable Trusts. https://www.pew.org/en/research-and-analysis/articles/2025/11/12/higher-educations-uncertain-fiscal-future
- Kaiser, J. (2026, February). NIH research grant funding rates plummeted in 2025. Science. https://www.science.org/content/article/nih-research-grant-success-rates-plummeted-2025
- National Institutes of Health, Office of Extramural Research. (2026, March). Fiscal year 2025 by the numbers: Extramural grant investments in research. NIH Extramural Nexus. https://www.grants.nih.gov/news-events/nih-extramural-nexus-news/2026/03/fiscal-year-2025-by-the-numbers-extramural-grant-investments-in-research
- National Science Foundation. (2025, May 30). FY 2026 budget request to Congress: Fellowships, scholarships, and postdoctoral programs [Summary table]. https://nsf-gov-resources.nsf.gov/files/09-fy2026.pdf
- National Science Foundation. (2026, April 13). NSF announces 2026 Graduate Research Fellowship Program award offers. https://www.nsf.gov/news/nsf-announces-2026-graduate-research-fellowship-program
- NSF has awarded almost 50% fewer grants since Trump took office. (2025, March 31). Science. https://www.science.org/content/article/nsf-has-awarded-almost-50-fewer-grants-trump-took-office
- Palmer, K. (2025, June 3). Details of Trump’s budget cuts alarm researchers. Inside Higher Ed. https://www.insidehighered.com/news/government/science-research-policy/2025/06/03/new-details-trumps-budget-cuts-alarm-researchers
- Ruediger, D. (2025, October 22). Federal funding cuts and research universities. Ithaka S+R. https://sr.ithaka.org/blog/federal-funding-cuts-and-research-universities/
- United for Medical Research. (2026, March 10). NIH’s role in sustaining the U.S. economy: 2026 update. https://www.unitedformedicalresearch.org/statements/umr-releases-annual-nih-economic-impact-report-2026-update/
- University of South Florida Sponsored Research. (n.d.). Facilities and administrative cost rates (on-campus organized research rate 50.0%, FY2025–26; a 15% cap is 70% below it). https://www.usf.edu/research-innovation/research-support/sponsored-research/fa-cost-rates.aspx
PhD Admissions Contraction
- Association of American Universities. (2026, July 7). New PhD admissions data show threat to U.S. STEM workforce. https://www.aau.edu/newsroom/leading-research-universities-report/new-phd-admissions-data-show-threat-us-stem-workforce
- Davis, S. (2025, February 5). Columbia proposes cutting majority of 2025–26 GSAS Ph.D. cohort, union says. Columbia Daily Spectator. https://www.columbiaspectator.com/news/2025/02/05/columbia-proposes-cutting-up-to-65-percent-of-2025-26-gsas-phd-cohort/
- FAS cuts science Ph.D. admissions by half. (2025, November). Harvard Magazine. https://www.harvardmagazine.com/university-news/harvard-cuts-phd-candidates-science
- Gerhard, D. (2025, February 28). US universities reduce PhD admissions in response to federal funding cuts. The Scientist. https://www.the-scientist.com/us-universities-reduce-phd-admissions-in-response-to-federal-funding-cuts-72734
- Mao, W. C., & Paulus, V. H. (2025, October 21). Harvard FAS cuts Ph.D. seats by more than half across next two admissions cycles. The Harvard Crimson. https://www.thecrimson.com/article/2025/10/21/fas-phd-admissions-cuts/
- Witze, A. (2025, October 21). US PhD admissions shrink as fears over Trump’s cuts take hold. Nature, 647, 15–16. https://doi.org/10.1038/d41586-025-03417-6
- Wosen, J. (2026, January 30). Tenuous biomedical funding has put first-year Ph.D. students in a bind. STAT. https://www.statnews.com/2026/01/30/first-year-phd-students-squeezed-tighter-research-funding/
USF-Specific Reporting
- Belcher, L. (2025, January 21). USF student orgs, departments might see budget cuts. The Oracle. https://www.usforacle.com/2025/01/21/usf-student-orgs-departments-might-see-budget-cuts/
- Carter, N. (2026, January 14). Funding cuts, fee hikes: How USF faced financial changes in 2025. Open Campus. https://www.opencampus.org/2026/01/14/funding-cuts-fee-hikes-how-usf-faced-financial-changes-in-2025/
- College of Medicine renamed, USF receives biggest gift in history. (2011, December). The Oracle. https://usforacle.com/?p=35139
- Marques, L., & Carter, N. (2026, January 13). USF nonresident students to see another fee hike this fall. Open Campus. https://www.opencampus.org/2026/01/13/usf-nonresident-students-to-see-another-fee-hike-this-fall/
- Meketa, T. (2026, January). USF rises in new research rankings, outpacing many peer institutions in growth. USF News. https://www.usf.edu/news/2026/usf-rises-in-new-research-rankings-outpacing-many-peer-institutions-in-growth.aspx
- University of South Florida Office of Research & Innovation. (2025–2026). Federal funding updates for USF researchers. https://www.usf.edu/research-innovation/news/2025/federal-funding-updates.aspx
- University of South Florida Research & Innovation. (n.d.). Overview: Technology incubator (economic impact of TBTI companies). USF CONNECT. https://www.usf.edu/research-innovation/rf/usf-connect/tbti/index.aspx
- University of South Florida Research & Innovation. (n.d.). USF start-up funding: Foundation BRAG and Seed Capital Accelerator Program. USF CONNECT. https://usf.edu/research-innovation/rf/usf-connect/funding-available/start-up-funding.aspx
- University of South Florida. (2014, October 10). USF announces a new name for College of Business. USF News. https://cloud.usf.edu/usf-news-archive/News/article/6567
- University of South Florida. (2018, June). USF officially designated as “Preeminent” by the Florida Board of Governors. USF News. https://www.usf.edu/news/2018/usf-designated-preeminent-by-florida-board-of-governors.aspx
- University of South Florida. (2024). USF research expenditures up 14%, surging to more than $461 million. USF News. https://usf.edu/news/2024/usf-research-expenditures-up-14-surging-to-more-than-461-million.aspx
- USF Morsani medical school No. 1 in Florida, among nation’s best, U.S. News & World Report says. (2025, April 9). Health News Florida / WUSF. https://health.wusf.usf.edu/health-news-florida/2025-04-09/usf-morsani-medical-school-no-1-florida-among-nation-best-us-news-world-report
- USF reports $531M in research activity for 2025, 15% climb over two years. (2026, March 10). Business Observer. https://www.businessobserverfl.com/news/2026/mar/10/usf-reports-research-activity/
- Vyas, M. (2025, October 21). USF student orgs hit with budget cuts as funding shortfall deepens. The Oracle. https://www.usforacle.com/2025/10/21/usf-student-government-organization-administration/
Investment and Funding Sources for Peer Venture Centers
- An entrepreneur’s lab rises in an old UMass dining hall. (2008, August 27). Dorchester Reporter. https://dotnews.com/node/659
- Babcock, S. (2017, April 27). Johns Hopkins opens FastForward 1812 in East Baltimore. Technical.ly. https://technical.ly/startups/fastforward-1812-johns-hopkins/
- Center for Entrepreneurship & Innovation expands opportunities to meet growing demand. (2023, August 18). EmoryBusiness.com. https://www.emorybusiness.com/2023/08/18/center-for-entrepreneurship-innovation-expands-opportunities-to-meet-growing-demand/
- CU Boulder Today. (2000, February 17). Alumni couple bolster CU-Boulder’s entrepreneurship program with a half million dollar professorship. University of Colorado Boulder. https://www.colorado.edu/today/2000/02/17/alumni-couple-bolster-cu-boulders-entrepreneurship-program-half-million-dollar
- David Eccles School of Business. (2025, May 2). Lassonde Entrepreneur Institute receives $25 million gift from the Lassonde Family Foundation. University of Utah. https://eccles.utah.edu/news/lassonde-entrepreneur-institute-receives-25-million-gift-from-the-lassonde-family-foundation
- Deshpande Center for Technological Innovation. (2025). Report to the President, FY2025. Massachusetts Institute of Technology. https://deshpande.mit.edu/
- Duke Today. (2012, May 11). Rubenstein gift launches Duke innovation and entrepreneurship initiative. https://today.duke.edu/2012/05/rubenstein-gift
- Emory University Office of Technology Transfer. (n.d.). Molnupiravir [Success story]. https://ott.emory.edu/about/success/molnupiravir.html
- Emory University. (2013, June 11). Drug development venture links translational research, business to launch new therapeutics. Emory News Center. https://news.emory.edu/stories/2013/06/drive_announcement/index.html
- Gilead Sciences. (2005, July 18). Gilead Sciences and Royalty Pharma announce $525 million agreement with Emory University to purchase royalty interest for emtricitabine [Press release]. https://www.gilead.com/news/news-details/2005/gilead-sciences-and-royalty-pharma-announce-525-million-agreement-with-emory-university-to-purchase-royalty-interest-for-emtricitabine
- Innovate Carolina. (2017). Innovate Carolina roadmap, 2010–2016. University of North Carolina at Chapel Hill, Office of Innovation, Entrepreneurship and Economic Development. https://innovate.unc.edu/app/uploads/2024/08/Full-Report-Innovate-Roadmap-FINAL-5-22-17-1.pdf
- Johns Hopkins University. (2016, November 29). A new home for innovation in East Baltimore: City, state officials join Hopkins leaders for 1812 Ashland ribbon-cutting. Hub. https://hub.jhu.edu/2016/11/29/1812-ashland-ribbon-cutting
- Johns Hopkins University. (2017, April 27). Startups get their start at Johns Hopkins’ new East Baltimore incubation space. Hub. https://hub.jhu.edu/2017/04/27/fastforward-1812-grand-opening/
- Keenan Family Foundation establishes Keenan Center for Entrepreneurship at the Ohio State University. (2018, June). Ohio State News. https://news.osu.edu/keenan-family-foundation-establishes-keenan-center-for-entrepreneurship-at-the-ohio-state-university/
- Lassonde Entrepreneur Institute. (n.d.). Our history. University of Utah. https://lassonde.utah.edu/about/our-history/
- MIT News. (2002). Deshpande gift launches MIT entrepreneurship center. https://news.mit.edu/2002/deshpande
- Schaffhauser, D. (2009, May 6). UMass Boston opens center to expand R&D activity and corporate partnering. Campus Technology. https://campustechnology.com/Articles/2009/05/06/UMass-Boston-Opens-Center-To-Expand-R-D-Activity-and-Corporate-Partnering.aspx
- School receives $30 million gift from Goizueta Foundation. (2019, December 4). EmoryBusiness.com. https://www.emorybusiness.com/2019/12/04/school-receives-30-million-gift-from-goizueta-foundation/
- U Celebrates groundbreaking for $45 million Lassonde Studios. (2014, October 10). KUER. https://www.kuer.org/education/2014-10-10/u-celebrates-groundbreaking-for-45-million-lassonde-studios
- UMass Boston’s Venture Development Center hits $1 billion funding milestone. (2019, May 6). VDC at UMass Boston. https://vdc.umb.edu/2019/05/06/vdc-hits-1b-funding/
- University of Kansas. (n.d.). KU Innovation Park. KU Places. https://places.ku.edu/buildings/ku-innovation-park
- University Record. (1999, July 19). $10 million gift from Sam Zell, Ann Lurie to create major entrepreneurial institute at business school. University of Michigan. https://record.umich.edu/articles/10-million-gift-from-sam-zell-ann-lurie-to-create-major-entrepreneurial-institute-at-business-school
- Venture Development Center, University of Massachusetts Boston. (n.d.). Venture Development Center [Collection page]. ScholarWorks at UMass Boston. https://scholarworks.umb.edu/vdc
- Zell Lurie Institute. (n.d.). History. University of Michigan. https://zli.umich.edu/about/history/
Cost Assumptions
- Association of University Technology Managers. (2015). AUTM salary survey: FY2014. https://autm.net/AUTM/media/SurveyReportsPDF/2014-AUTM-Salary-Survey.pdf
- University of South Florida Sponsored Research. (n.d.). Implementation of pooled fringe rates (FY2025 rates). https://usf.edu/research-innovation/sr/pooled-fringe-rates.aspx
Technology Transfer Offices of the Interview Institutions
- Duke Today. (2021, May 10). University redoubles efforts to convert research into social impact. Duke University. https://today.duke.edu/2021/05/university-redoubles-efforts-convert-research-social-impact
- Johns Hopkins University. (2014, May). Report of the Committee on the Innovation Ecosystem. https://ventures.jhu.edu/innovation-report/
- Johns Hopkins University. (2015, March 4). Johns Hopkins details $40M plan to support innovation, entrepreneurship. Hub. https://hub.jhu.edu/2015/03/04/innovation-ecosystem-implementation-plan/
- Mueller, P. K. (2015, October 22). UC San Diego’s new office is ‘your partner in innovation.’ UC San Diego News Center. https://library.ucsd.edu/dc/object/bb5128437m/_1.pdf
- Penn scientists’ Nobel-winning vaccine research has earned more than $1 billion for the university. (2023, October 3). The Philadelphia Inquirer. https://www.inquirer.com/health/nobel-prize-covid-19-vaccine-mrna-moderna-pfizer-biontech-licensing-20231003.html
- UC San Diego Office of Innovation and Commercialization. (n.d.). Office of Innovation and Commercialization. https://innovation.ucsd.edu/explore-centers/oic/index.html
- University of Utah. (n.d.). Welcome to the Technology Licensing Office. @TheU. https://attheu.utah.edu/announcements/welcome-to-the-technology-licensing-office/
USF / UF Comparison
Standing institutional data sources are cited by publisher/URL rather than a single dated article, consistent with how recurring datasets are normally referenced.
- Florida Board of Governors. (2026, March 25). Florida Board of Governors highlights research momentum and strategic advancements across the State University System. State University System of Florida. https://www.flbog.edu/2026/03/25/florida-board-of-governors-highlights-research-momentum-and-strategic-advancements-across-the-state-university-system/
- National Academy of Inventors. (2026, February 12). NAI announces Top 100 Worldwide Universities granted U.S. utility patents of 2025. https://academyofinventors.org/nai-announces-top-100-patenting-universities-worldwide-of-2025/
- National Center for Science and Engineering Statistics. (annual). Higher Education Research and Development (HERD) Survey (FY2021 institutional data). National Science Foundation. https://ncses.nsf.gov/surveys/higher-education-research-development
- U.S. News & World Report. (n.d.). University of South Florida overall rankings. Best Colleges. https://www.usnews.com/best-colleges/university-of-south-florida-1537/overall-rankings
- UF Innovate. (n.d.). The Hub. University of Florida. https://innovate.research.ufl.edu/the-hub
- University of Florida. (2012, October 12). Innovation Hub reports 85 jobs and $7.2 million in private investment in 10 months. UF News. https://archive.news.ufl.edu/articles/2012/10/innovation-hub-reports-85-jobs-and-72-million-in-private-investment-in-10-mon.html
- University of Florida. (2016, July 6). A record-breaking year for moving UF technologies to market. UF News. https://archive.news.ufl.edu/articles/2016/07/a-record-breaking-year-for-moving-uf-technologies-to-market.html
- University of South Florida Office of Decision Support. (2025–2026). Common Data Set. https://www.usf.edu/ods/documents/cds/usf-cds-2025-2026-final-v2.pdf
- University of South Florida Office of Decision Support. (n.d.). USF Fact Book. https://www.usf.edu/ods/data-tools/facts.aspx
- University of South Florida Research & Innovation. (2026, February). USF ranks among top 20 public universities for new patents in 2025. https://www.usf.edu/research-innovation/news/2026/usf-ranks-among-top-20-public-universities-for-new-patents-in-2025.aspx
- University of South Florida. (2023, June 1). University of South Florida accepts invitation into the Association of American Universities. USF News. https://www.usf.edu/news/2023/university-of-south-florida-accepts-invitation-into-the-association-of-american-universities.aspx
Published Literature on Technology Transfer Performance
- Bercovitz, J., Feldman, M., Feller, I., & Burton, R. (2001). Organizational structure as a determinant of academic patent and licensing behavior: An exploratory study of Duke, Johns Hopkins, and Pennsylvania State Universities. Journal of Technology Transfer, 26(1–2), 21–35. https://doi.org/10.1023/A:1007828026904
- Chapple, W., Lockett, A., Siegel, D., & Wright, M. (2005). Assessing the relative performance of U.K. university technology transfer offices: Parametric and non-parametric evidence. Research Policy, 34(3), 369–384. https://doi.org/10.1016/j.respol.2005.01.007
- Di Gregorio, D., & Shane, S. (2003). Why do some universities generate more start-ups than others? Research Policy, 32(2), 209–227. https://doi.org/10.1016/S0048-7333(02)00097-5
- Siegel, D. S., Waldman, D., & Link, A. (2003). Assessing the impact of organizational practices on the relative productivity of university technology transfer offices: An exploratory study. Research Policy, 32(1), 27–48. https://doi.org/10.1016/S0048-7333(01)00196-2
Author’s Note
- The Nobel Prize. (2003). The Nobel Prize in Physiology or Medicine 2003: Paul C. Lauterbur and Sir Peter Mansfield. https://www.nobelprize.org/prizes/medicine/2003/summary/